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 Health is a perfect state of physical, psychological, social and spiritual 
well being of an individual.  Siddha is one of the oldest medical system in the 
world which was originated by Siddhars.   
 According to Siddha medical science the universe originally consists of 
atoms which contributed to the five basic elements viz.  Earth, Water, Fire, Air, 
and Ether.  Human body is also made up of these five basic elements called 
panchaboothams which maintain the integrity of natural humours called 
Vatham, Pitham and Kabam.  Derangement of Vatham, Pitham and Kabam 
results in disease. 
 Skin is an index of many systemic and genetic disorders.  The goal of 
pediatric care is to maximize each child’s potential.  Bala karappan is the major 
health hazard which affects the child’s physical and mental strength. 
 Here I have brought out a new drug named NANNARI VER ENNAI 
(BOTH INTERNAL AND EXTERNAL).  The all ingredients of Nannari Ver 
Ennai are all plant origin and very safe to use in pediatric practice. 
 The disease was studied in 50 Out patients and In patients in the Post 
Graduate Department of Kuzhanthai Maruthuvam at Government Siddha 




AIM AND OBJECTIVES 
  BALA KARAPPAN is a major health hazard in the developing countries 
like India.  It affects children in their active period of life and cause severe 
embarrassment. 
 Dermatitis and eczema are a common problem all over the world.  Their 
incidence is 2-3 percent of all medical problems seen in practice. 
 The prevalance of all forms of eczema was 18 per 1000, seven of whom 
had ATOPIC DERMATITIS.  Atopic dermatitis is the most common chronic 
relapsing skin disease seen in infancy and childhood.  It affects 10-20% of 
children worldwide. 
 Incidence of Atopic eczema was 5%.  Atopic Dermatitis was by for the 
more common found up to the age of 11 years. 
 Hence this study was carried out with an intention to formulate an proper 
treatment of Balakarappan. 
 To evaluate and clinically assess the therapeutic effect of  NANNARI 
VER ENNAI in curing BALA KARAPPAN and to reduce the recurrence of 
symptoms. 
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 To create awareness among the patients and their parents about the 
disease and its complications and educate them to improve their dietary habits 
and life style modifications. 
 
OBJECTIVES 
• To recollect and review various siddha  literatures about BALA 
KARAPPAN. 
• To know the extent of correlation of etiology, symptoms and signs of 
Bala Karappan. 
• To make comparative study of Bala Karappan with Atopic 
Dermatitis. 
• To study the Biochemical and pharmacological actions of the trial 
drug along with analysis of siddha investigation methods such as 




REVIEW OF LITERATURE 
 
SIDDHA ASPECTS 
 ghy fug;ghd;;; ; vd;gJ gjpndl;L tifahd fug;ghd;fspy; xd;whFk;. 
ghy fug;ghd; Foe;ijfSf;F cz;lhFk; gpzp MFk;.  ghythflk; 
E}ypy; tpsf;fg;gl;Ls;s FwpFzq;fspd; mbg;gilapy; Nehapidf; 
fzpj;J> rpj;j kUj;Jt Kiwj; Njh;Tfshd Kf;Fw;w NtWghLfs;> 
VOtif clw;jhJf;fs;> Fw;wq;fspd; jd;dpiy tsh;r;rp> Ntw;Wepiy 
tsh;r;rp> gpzpawpKiwik> vz;tifj;Njh;Tfspd; mbg;gilapy; Nehapid 
Muha;e;J mjw;fhd gpzpePf;f KiwAk;> Neha; tuhky; jLf;Fk; topfSk; 
,jpy; tpsf;fg;gl;Ls;sd. 
 
NtWngah;fs;; ;; ;; ; 
 thiy fug;ghd;  
ghiy fug;ghd; 
         
fug;ghd; Neha; ,ay;; ; ; ;; ; ; ;; ; ; ; 
 clypy; jpkph;> jpdT> nrhwp> Gz;> jbg;G> ntbg;G> ePHf;frpjy; Mfpa 
FwpFzq;fis cz;lhf;fp clk;gpd; ,aw;if epwj;ij NtWgLj;Jk; 
Neha; 
        - ghythflk;;;; 
  
cly; KOtJk; Gz;> jbg;G ,uzj;ij cz;lhf;fp nfhg;Gsq;fs; 
fz;L Njhypd; epwj;ij NtWgLj;jp rpy Ntis ntbg;G> ePH frpjiy 
cz;lhf;fp twl;rpia Vw;gLj;Jk; Njhiyg; gw;wpa ,uz Neha;.  
    - gps;is gpzp kUj;Jtk; ,uz;lhk; ghfk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
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Neha; tUk; gUtk;; ; ;; ; ;; ; ; 
 Foe;ijfsJ jhyg; gUtk; Kjy; tUifg;gUtk; tiuAs;s ehd;F 
gUtq;fspYk; fug;ghd; Neha; Foe;ijfSf;F cz;lhff;$Lk;. 
 ,ak;GjpkpH fha;r;ry; ,aq;Fe; jpul;rp; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ;  
 jaq;F fze;Njhd;We;jhd; fug;ghd; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; ; ;;; - eak;glNt;;;  
 te;J}Wk; khf;fzj;jpy; thjf;fug;ghd;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; 
        - ghythflk;;;; 
 ghYz;Zk; gUtk; Kjy; ghYk; NrhW cz;Zk; gUtk; tiu 
Foe;ijfisj; jhf;FfpwJ. 
     - gps;isg;gpzp kUj;Jtk; ,uz;lhk;ghfk;; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; 
 
Foe;ijfis Neha; tijf;Fk; ehs;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
 fowhd fug;ghd;jhd; gpwtp Nehf;fpf;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
  fz;lKjy; ehs;njhlq;fpj; jpq;fs; %d;W; ; ; ; ; ; ; ;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ;  
 Gowhd Fotpfis tijf;Fk; fhyk;.................; ; ;; ; ;; ; ;  
- gjpnzz; rpj;jh;fs; itj;jpa rpy;yiuf; Nfhit ; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ;  
 
  Nkw;fhZk; Mjhu E}y;fspd; mbg;gilapy; ghy fug;ghd; vDk; 
Neha; Foe;ijfspd; jhyg; gUtk; Kjy; tUifg; gUtk; tiu tUnkd 
$wg;gbDk;> ghyfug;ghd;  ghyh;fspy; 1 Kjy; 12 taJ tiu 
njhlh;fpd;wJ. 
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Neha; tUk; top; ;; ;; ;  
ghythflk; E}ypy;; ;; ;; ; 
  “gpwe;jehs; gps;isf;Fj; jhNd ed;wha;; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; 
   gpjhthNy gpzpAlypd; NkNy Njhd;Wk;; ; ;; ; ;; ; ; 
  rpwe;j gpzp fzkhe;jk; ; ; ;; ; ;; ; ; fug;;;;;; ;;ghd; Njhlk; ; ;; ;; ;  
   jPjhF kf;fuq;fs; fpue;jp Kd;dhk;P ; ; ; ; ; ;P ; ; ; ; ; ;P ; ; ; ; ; ; 
  mwe;jiof;F ; ;; ;; ; kUe;jwpiQah;;; dhw; jPUk;; P ;; P ;; P ; 
   mJtd;wp kUe;jwpQ; ;; ;; ; dhdhw; jPUk;; P ;; P ;; P ; 
  jpwe;njwpe;J ghHj;JtpL rpW gps;isf;Fr;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
   rPuhf tU Neha;fs; nrg;gf; NfNsP ; ; ; ;P ; ; ; ;P ; ; ; ; ” 
 Rf;fpy RNuhzpjk; fye;J fU cz;lhFk; NghJ> je;ijapd; 
czthjp nray;fspd; Fw;wj;jpdhy; rpRtpw;F gy gpzpfs; jhapd; 
tapw;wpypUe;J ntspte;jTlNdNa Njhd;Wk;.  mt;thW Njhd;Wk; 
gpzpfspy; fug;ghDk; xd;whFk;.  vdNt fug;ghd; fUtpy; Njhd;Wk; Neha; 
MFk;. 
  ngUFQ; Nrhs kpWq;;; ;Fk; ngUq;fk;G; ; ; ;; ; ; ;; ; ; ;  
  tuF fhUld; thioapd; fhnahL; ;; ;; ;  
  ciunfhs; ghfw; nfspw;W kPd; cz;bby;; ; ; P ; ; ;; ; ; P ; ; ;; ; ; P ; ; ; 
  tphpt jha;f; fug;ghD kpFe;jNj; ; ; ;; ; ; ;; ; ; ;  
        - ghythflk; 
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 Nrhsk;> fk;G> tuF> fhuhprp> thiof;fha;> ghfw;fha;> nfspw;W kPd; 
Nghd;w czthjp nray;fspdhy; fug;ghd; gpzp cz;lhff;$Lk;> NkYk; 
,e;j czthjpfis gpzp cs;s NghJ vLj;Jf; nfhz;lhy; gpzp 
kpFjpg;gLk;. 
 
Mj;kul;rhkph;jnkd;Dk; itj;jpa rhu rq;fpufk; E}ypy;; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ; 
ghNu Foe;ijg; gpzpf;Fwpg;Gk; gfUk;gl;rp Njh; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; \Kld;;;; 
NeNu khe;jk; gjpndl;Lk; NeUq;fpue;jp jd; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; ;FzKk;; ;; ;; ; 
rPNuGzh;r;rpf; fhe;jyJQ; rpwe;jfh;g;gr; #LKjy;P ; ; ; ; ; ; ; ; ; ;P ; ; ; ; ; ; ; ; ; ;P ; ; ; ; ; ; ; ; ; ; 
NeNukhe;j uwpantd;W epiwahAiuj;j jpJthNk; ; ;; ; ;; ; ;  
      
 fpue;jp> gl;rp Njh\k;> khe;jk;> fzk;> fug;ghd;> mf;fuk;> nrt;thg;G> 
njhz;ilf;fl;L> it#hp Kjyhd mNef Nuhfq;fs; Foe;ijfSf;F 
rk;gtpf;fpd;wJ.  khe;jk; jhapd; Kiyg;ghyhYk;> fzk; fh;g;gr; 
#l;bdhYk; kw;wg; gpzpfshd fug;ghd; Nghd;wit jha; je;ijapd; 
Gzh;r;rpapdh nyOe;j #l;bdhY Kz;lhfpwJ. 
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gps;isg;gpzp kUj;Jt E}ypy;; ; ; ;; ; ; ;; ; ; ; 
  “Vohd fug;ghd; jd; cw;gj;jp NfS; ; ; ; ;; ; ; ; ;; ; ; ; ;  
   Naj;jklh khq;fp rq;fs; Grpf;ifahYk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
$ohd fk;G jpid tuF rhik;;;  
  nfhbjhd fpoq;Ftif aUe;jyhYk;; ; ;; ; ;; ; ; 
ghohd ngz;kha;if jd;dpy; rpf;fp; ; ; ; ;; ; ; ; ;; ; ; ; ;  
  ghq;fhd tpfj;jhd Kaw;rpahYk;; ; ; ;; ; ; ;; ; ; ; 
jhohd gz;lfq;fs; rikj;Jj;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
  jpd;dy; jhf;FNk fug;ghdpd; rhay; jhNd; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; ” 
khkprq;fs; Grpg;gjhYk;> fk;G> jpid> tuF> rhik> fpoq;F 
tiffis cz;gjpdhYk;> ngz; ,r;ir cilath;fshYk;> jho;thd 
gz;lq;fis rikj;J cz;gjpdhYk; fug;ghd; gpzpahdJ cz;lhfpwJ 
vd rpj;j kUj;Jt E}y;fs; $Wfpd;wd. 
 
kjiy Neha; E}ypy;; ;; ;; ; - njhFjp – I 
  fug;ghd; je;ijahy; Nkfj;jhYk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
   fUthd Njh\q;fs; tp; ;; ;; ; \j;jpdhYk;; ;; ;; ; 
  Nfhg;ghd fpue;jpapdhy; fh;kj;jhYk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
   nfhq;ifghy;; ;; ;; ; Fbj;jke;j fpUkpahYk;; ; ;; ; ;; ; ; 
  jhg;ghd fug;gdJ mZfpf;nfhs;Sk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
   rj;jpa kha;r; nrhy;YfpNwd; jfik NfS; ; ; ; ;; ; ; ; ;; ; ; ; ;  
  Vw;ghd fug;ghdJ <nuhd;g jhFk;; ; ; ;; ; ; ;; ; ; ; 
   ,jpd;NkNy mTjq;fs; FwpAk; NfNs.; ; ; ;; ; ; ;; ; ; ;  
       ifnaOj;Jg;gpujp 98; ;; ;; ; -150-151 
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   Nkfj;jpdhy; ghjpf;fg;gl;l je;ijapd; Njh\Ks;s tpe;Jtpdhy; 
fUcw;gj;jpahFk; NghJ Njhlj;jpdhy; ghjpf;fg;gLfpd;wJ. gpd;G fU 
Foe;ijahf ntspNa te;J mj;Njhlk; njhlh;fpd;wJ. Mfhu 
NtWghLfspdhy; cz;lhd Njh\k; cs;s jha;ghiy Foe;ij mUe;jp 
ke;jKz;lhfp> mg;NghJ cz;lhFk; fpUkpfshYk; fug;ghd; cw;gj;jp 
Mfpwnjd E}y;fs; $Wfpd;wd. 
 
mfj;jpah; fd;k fhz;lk; 300 E}ypy;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
  cz;iknad;w fug;ghNdhL tz;L fbFl;l; ; ; ; ;; ; ; ; ;; ; ; ; ;  
  KfpYs;NshHf;fpJ te;j cz;ikNfS; ; ; ;; ; ; ;; ; ; ;  
  jd;ik nad;w jpy;yhk Xjhrpdq;fs; Ngr; ; ; ; ;; ; ; ; ;; ; ; ; ;  
  rw;FUit J}ldpj;j rz;lhsj;jhy;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
td;iknad;w topapNy Ks; spl;L itj;jy;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
  kue;jiofs; G+Tjpu; ;; ;; ;  tbj;j ghtk;; ;; ;; ; 
  ngz;ikapNy tz;Lfb tplKQ; Nrh;j;J; ; ; ; ;; ; ; ; ;; ; ; ; ;  
  gpyj;j nrhwp Fl;lkJ gpyj;j thNw; ; ;; ; ;; ; ; ” 
  Nkw;fhZk; nra;As; ciug;gJ ahnjdpy;> tz;LfbapdhYk;> fd;k 




  Ntff; fhw;wjpdh; gidnty;yj;jhy;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
   ghf kpf;fyhd; Nkjp; ;; ;; ; g; ghntapyhy;; ;; ;; ; 
  jhfkhdp tUf;f jprhHjyhy;; ;; ;; ; 
   Nkhf thio tOjiy Ks;spf;fhs;; ; ;; ; ;; ; ; 
  fhAk; gy;yplj; jhw;Ruj; jhw;fspy;; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; 
   vAk; tz;nlypahy; tUNk  Jntsp; ; ;; ; ;; ; ;  
  Fb ey;ywpthd vUtpdhH;;;  
   ahd khdfug;ghd; tiffNs.; ;; ;; ;  
 mjpfkhd fhw;W> mjpf ntapy;> gidnty;yk;> thiof;fha;> 
tOjiy> Ks;spf;fha; KjyhditfshYk; tz;L> vyp Kjypait 
fbj;jyhYk; fug;ghd; gpzp cz;lhfpd;wJ. 
 
Nuhf eph;za rhuk; E}ypy;; ; ;; ; ;; ; ; 
 Mfhuk; gprFjy;> gOf;fhj goq;fs;> gUg;G tiffs;> gytpj 
khkprq;fs;> m[Puz t];Jf;fs; ,itfis Foe;ijapd; jha; Grpg;gjhy; 
Foe;ijfSf;F fug;ghd; Nuhfq;fs; tUfpd;wJ. 
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Neha; vz;; ;; ;; ; 
 ghy thfl E}ypy; $wg;gl;Ls;s fug;ghdpd; Neha; vz; ; ;; ;; ; - 18 
 
  Kj;Njhl khpA+J #iy;;;  
   Kd;Dntb kz;ilnghhp rl;il; ; ;; ; ;; ; ;  
  rw;NwhL fUiknahL nrk;ik; ;; ;; ;  
   jdpf;nfhs;sp NjhlnkhL ; ;; ;; ; thiy 
  Kw;Nwhy;t ul;rpnahL tPq;fy;; ; ; P ; ;; ; ; P ; ;; ; ; P ; ; 
   %hptUk; ;;; gjpndl;L;;;  tifahk;;;; 
  nfhj;jhd fug;ghd;f nsd;W; ; ; ;; ; ; ;; ; ; ;  
   $wpdhH gz;ilNah uhkhy;; ;; ;; ; 
  nrq;fug;ghd; mdy;fug;ghd; jhDk; kz;ilr;; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ; 
   rpuq;Fgz;Zk; mhpfug;ghd; nghhpf ug;ghd;; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; 
  mq;fkjp nyOfug;ghd; jhD kpf;f; ; ; ;; ; ; ;; ; ; ;  
   msuhk;cjp uf;fug;ghd; fl;bNahL; ; ; ; ;; ; ; ; ;; ; ; ; ;  
  nghq;fkha; tPq;fp fug;gh De;jhd;; ; P ; ; ; ;; ; P ; ; ; ;; ; P ; ; ; ; 
   Gfyhpa rl;iljb n;;; tbfug;ghd;; ;; ;; ; 
  rpq;fKf vhpfug;ghd; thj gpj;jr;; ; ; ; ;; ; ; ; ;; ; ; ; ; 








6. #iy fug;ghd; 
7. ntbfug;ghd; 
8. kz;ilf; fug;ghd; 
9. nghhp fug;ghd; 
10. rl;il fug;ghd; 





16. thiy fug;ghd; (ghy fug;ghd;); ; ; ;; ; ; ;; ; ; ;  
17. tus; fug;ghd; 
18. tP;q;F fug;ghd; 
 
fug;ghd; jPUk; jPuh epiy; ; P ; P; ; P ; P; ; P ; P -  
gjpndd; tif fug;ghd;fspy; nfhs;spf; fug;ghd; jPuhJ. gjpNdO 
fug;ghd; jPUk;. ghy fug;ghd; jPUk; gpzp MFk;. 
 
NtW E}y;fspy; fug;ghdpd; tiffs;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
 mfj;jpah; 2000    - 66 
 FUehb rh];jpuk;    - 85 
 b.tp.rhk;gtrptk; gps;is mfuhjp - 29 
 gps;is gpzp kUj;Jt E}y;  - 54 
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 ghy itj;jpa Nghjpdp E}y;  -  9 
 A+fp itj;jpa rpe;jhkzp  -  7 
 mfj;jpah; uz E}y;   - 80 
 Fk;gKdp ghythflk;   - 18 
 mfj;jpah; 2000> 3-k; ghfk;  -  6 
,t;thW gy;NtW E}y;fspy; fug;ghdpd; tiffs; gythW 
$wg;gl;bUe;jhYk; ghythfl E}ypy; $wg;gl;Ls;s 18 tif fug;ghd;fspy; 
“ghy fug;ghd;” Ma;thshpd; Ma;Tf;fhf vLj;Jf; nfhs;sg;gl;Ls;sJ 
 
thiy fug;;;;;; ;;ghdppd;;;;;; ;; FwppFzq;;;;;; ;;fs;;;;;; ;; 
ghythfl E}ypy;;;; 
  fhyJ fLf;FQ; re;J; ; ;; ; ;; ; ;  
   fz;lKk; ntbj;Jg; Gz;zha;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
  VyNt fbtplk; Nghy;; ;; ;; ; 
   ,Uj;Jgd; dPH Nghy; gha;e;J; ; P ; ; ;; ; P ; ; ;; ; P ; ; ;  
Nfhykha; tw;wp ; ;; ;; ; ehWk;;;; 
   FotpA nkhLq;F khfpy;; ;; ;; ; 
khyUq; Foyha; thy  ; ;; ;; ;    
  fug;ghd;nra; thW jhNd; ; ;; ; ;; ; ;  
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fhy;fuq;f NshL re;J; ; ;; ; ;; ; ;  
  Nktypfshfpa fbtplq;fs; Nghy; ;; ;; ;  
Nky;jbj; jjpYk; ePH gwpe;J; ; ; P ;; ; ; P ;; ; ; P ;  
  kfs;nka; nahLq;fp a; ; ;; ; ;; ; ; puzq;;;;fsha;;;; 
%y ehspDs; njhz;ilNahL; ;; ;; ;  
  tpuzq;f shfpKjph; ntg;gkhk;; ; ; ;; ; ; ;; ; ; ; 
thiyahd fug;ghdpn;;; jd;wTk;; ;; ;; ; 
  jq;fS;;; Q;;;; rpwpJ itj;jpNl;;;  
 
gzpthd tpfhuKw; wNdfq; $wha;; ; ;; ; ;; ; ; 
guguj;J Njfnky;yhe; nrhwpNgh yhfp; ; ;; ; ;; ; ;  
gpzpahd rhiuAly; NghNy fhZk;; ;; ;; ; 
  gpzpthapy; tplye;jhd; cjpuk;Nghy; ; ; ;; ; ; ;; ; ; ;  
jpdpahd Fiytw;wp jpUt ope;J; ;; ;; ;  
  jprjhJ gPlnky;yhk; eLe Lq;fpP ; ; ;P ; ; ;P ; ; ;  
tdpahd ,f;Fzq;fs; fz;l jhdhy;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
  thyfug; ghdJntd; wpak;g yhNk; ; ;; ; ;; ; ;  
      gf;fk; vz; ; ; ;; ; ;; ; ; - 398 
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ghly; tpsf;fk;; ; ;; ; ;; ; ;     
guguntd;W Njfnky;yhk;             
nrhwpNghy; cz;lhFk;.                    
- Atopic Dermatitis is a chronic pruritic 
inflammation of the skin 
rhiuAly; NghNy fhZk;        - Xerosis is the hall mark of Atopic Dermatitis 
fhy;> fuq;fs;> re;J> 
fz;lk; ,t;tplq;fspy; 
cz;lhFk;  
- Common site of Atopic Dematitis is folds of 
the elbows, behind the knees, flexural 
surfaces of the upper and lower limbs and 
sides of the neck. 
 
fbtplq;fs; Nghy 
jbj;Jf;fhZk;                   
- Atopic dermatitis is a chronic 
inflammatory skin condition characterised 
by itchy papules, papulovesicular lesions 
consists of erythema and discrete confluent 
oedematous papules. 
fbtplq;fspy; gd;dPH Nghy 
ePHgwpe;J mit tw;wp ehWk;.  
gpzpthapy; tplrykhdJ 
cjpuk; Nghd;W tbAk;. 
- Papules are intensely itchy resulting in 
oozing and may become exudative and 
crusted as a result of rubbing. 
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,uzq;fsha; khWk;. - Abrasion of the epidermis due to 
secondary bacterial and viral infections. 
Foe;ijapd; nka;nahLq;Fk;   - In Infantile eczema child is irritable and 
weak. 
njhz;ilapy; tpuzk; 
cz;lhFk;   
- Atopic Dermatitis is associated with a 
personal or family history of hay fever, 
asthma and allergic rhinitis.  In allergic 
diseases intermittent dry cough resulting in 
inflammation of the throat. 
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Kf;Fw;w NtWghLfs;; ; ;; ; ;; ; ; 
 thjf; Fw;wkhdJ Ntw;Wepiy tsh;r;rpailtijj; njhlh;e;J fgf; 
Fw;wk; Nflile;J ,Wjpapy; gpj;j Fw;wk; jd;dpiyapypUe;J gpwo;tjhy; 
fug;ghd; gpzp cz;lhfpd;wJ. 
 
Kf;Fw;wq;fSk; mtw;wpd; nra;njhopYk; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; ; 
thjk;;;; 
thjkhdJ ,aw;if epiyapy; epd;W Cf;fKz;lhf;fy;> kyk; 
Kjypa gjpdhd;F tpiuTfis ntspg;gLj;Jjy;> rhuk; Kjypa VO 
clw;fl;Lfl;LfSf;Fk; xj;j epfo;r;rpiaj; juy;> Ik;nghwpfl;F 
td;ikiaf; nfhLj;jy; Mfpa njhopy;fisg; GhpAk; 
 
tsp clypy; nra;njhopy;; ; ;; ; ;; ; ; 
 ePHg;girapd;ik (twl;rp) 
 ,isj;jy; 
 kyk; milgLjy; 
 Njhy; fWj;Jf; fhzy; 
thjj;jpd;; ;; ;; ; 
tiffs;;;; 
nra;njhopy;; ;; ;; ; 
ghy fug;ghd; gpzpapy; ; ; ;; ; ;; ; ;
Fw;wq;fspd; epiy ; ; ;; ; ;; ; ;
ghjpg;G;;; /,ay;G;;;  
gpuhzd;;;; 
%r;Rtply;> thq;fy;> Jk;ky;> Vg;gk; 




md;drhuj;ij Nru Ntz;ba ,lq;fspy; 
Nrh;g;gpf;Fk;. ntz;zPH> ehjk;> kyk;> 
rpWePH> fU ,tw;iw ntspg;gLj;Jk; 
ghjpg;G - kyf;fl;L 
cz;lhjy; 
tpahdd;;;; 
cz;Zk; cztpd; rhuj;ij 
mt;tt;tplq;fspy; epiwg;gpj;J cliyf; 
fhf;Fk;. elj;jy;> cly; cWg;Gfis 
mirj;jy;> fz; ,ikj;jy;> tpopj;jy; 





cztpd; rhuj;ij $bapUe;J mq;NfNa 
epWj;Jk;.  Kaw;rp> kdjplk;> cly; 
td;ik> cly; epwk;> cly; xsp> 
epidg;G Mfpa ,tw;iwAk; 
cz;lhf;Fk;. 
ghjpg;G - cly;td;ik> 
cly; epwk;> cly; xsp 
Fiwjy;. 
rkhdd;;;; 
kw;w thAf;fis kpQ;rnthl;lhkw; 
klf;fpr; rhpg;gLj;jpr; Nrur;nra;Ak;.  
czTg;nghUl;fs; nrhpg;gjw;Fhpa jPia 
tpUj;jp nra;J rhuj;ijAk;> jpg;gpiaAk; 
gphpj;J rhuj;ij clypd; vy;yhg; 
ghfq;fSf;Fk; gfph;e;J nfhLj;J 
tsh;f;Fk;. 
ghjpg;G - kw;w 
Fw;wq;fs; ghjpg;G 
ehfd;;;; 
vy;yhf; fiyfisAk; fw;Fk;gb 




kdjpypUe;J fpsk;gp fz;zpy; epd;W 
,ikiaf; nfhl;Ltpf;Fk;.  nfhl;lhtp 
tplg;gz;Zk;.  thia %lr; nra;Ak;. 
,ay;G 
fpUfud;;;; 
ehtpypUe;J ehtpw;frpitAk;> ehrpapw; 
frpitAk; cz;lhf;Fk;.  kpFe;j 
grpiaAz;lhf;fr; nra;Ak; 
,ay;G 
Njtjj;jd;; ;; ;; ; 
Nrhk;giyAk;> cly; Khpj;jiyAk; 
cz;lhf;Fk;. jhq;Fjy;> rz;il 
nfhs;sy;> jh;f;fk; Ngry;> kpFe;j 
Nfhgk; Kjypatw;iwAz;lhf;Fk; 
ghjpg;G – cly;NrhHT 
jdQ;nrad;; ;; ;; ; 
%f;fpypUe;J jbj;J clk;G KOikAk; 
tPq;fg;gz;Zk; 
        -       
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gpj;jk;; ;; ;; ; 
 ,aw;if epiyapdpd;W nrhpg;gpj;jy;> ntk;ik> ghHit> grp> 
ePHNtl;if> Rit> xsp> epidg;G> mwpT> td;ik> nkd;ik ,itfis 
cz;lhf;fp clw;Fj;Jiz GhpAk;. 
 
moy; clypy; nra;njhopy; ; ;; ; ;; ; ; ; 
 clypy; ntg;gk; cz;lhjy;>  nkypT> vhpT ,itAz;lhjy;. 
 nre;ePH jd; mstpy; kpFjy;. 
moypd;;;; 
gphpTfs;;;; 
nra;njhopy;; ;; ;; ; 
ghy fug;ghd; ; ;; ;; ;
gpzpapy; ;;;
Fw;wq;fspd; ; ; ;; ; ;; ; ;
epiy 
ghjpg;G;;; /,ay;G;;;  
mdw;gpj;jk;; ; ;; ; ;; ; ; 
jPapd; Fzj;ij kpFjpahfg; ngw;W ePH 
tbtKs;s nghUs;fis twsr; nra;J 
cz;l czTg; nghUs;fisr; nrhpf;Fk;gb 
nra;Ak;. 
ghjpg;G 
,uQ;rfg; ; ;; ;; ;
gpj;jk;;; ; 
cztpypUe;J gphpe;Jz;lhd rhWf;Fr; 
nre;epwj;ijj; jUfpwJ. ,ay;G 
rhjfg; ;;;
gpj;jk;; ;; ;; ; 
epiwNtw;Wk; gz;GilaJ.  tpUg;gkhd 
njhopiyr; nra;J Kbf;Fk;. ,ay;G 
MNyhrfg; ;;;
gpj;jk;; ;; ;; ; 
fz;fspy; tho;e;J nfhz;L vy;yhg; 




gpj;jk;; ;; ;; ; 
NjhYf;F xspiaj; jUk; gz;GilaJ.  
Njhypy; tho;e;J nfhz;L NjhYf;F xspiaf; 
nfhLj;J mij xspur; nra;Ak;. 
chpnahspnra; aoy;jq;Fe; Njhyp yj;ij; ; ; ; ;; ; ; ; ;; ; ; ; ;  








,aw;if epiyapy; epd;W epiyj;jy;> grp> ePHNtl;if> Jauk;> 
fyf;fk;> ntg;gk; ,itfisg; nghWj;Jf; nfhs;Sjy;> fPy;fspd; 
mikg;gpw;F td;ik jUjy; Mfpa njhopy;fisg; GhpAk;. 
Iak; clypy; nra;njhopy;; ; ; ;; ; ; ;; ; ; ; 
 nrhwp (jpdT) 
 Cz;tpiutpy; nrhpahik 




Iaj;jpd;; ;; ;; ; 
gphpTfs;;;; 
nra;njhopy;; ;; ;; ; 
ghy fug;ghd; ; ;; ;; ;
gpzpapy; Fw;wq;fspd; ; ; ; ;; ; ; ;; ; ; ;
epiy ghjpg;G;;; /,ay;G;;;  
mtyk;gfk;;; ; 
EiuaPuypy; ,Ue;J nfhz;L> 
jkufj;jpw;F mbg;gilaha; ,Ue;J kw;w 




cz;zg;gl;l czTg; nghUs;fis 




,J Ritg; nghwpahfpa ehtpdpd;W 
cz;Zfpw Ritfis mwptpf;Fk; 
njhopiyg; GhpAk; 
,ay;G 
jw;gfk;; ;; ;; ; 
,J jiyapdpd;W fz;fSf;F 
FspHr;rpiaj; jUk; 
,ay;G 
re;jpfk;; ;; ;; ; 
G+l;Lfspy; epd;W ,aw;ifaha; vy;yhf; 
fPy;fisAk; xd;Nwhnlhd;W nghUj;jpj; 





jhJf;fs;; ;; ;; ; 
nra;njhopy;; ;; ;; ; 
fug;ghd; gpzpapy; ; ; ;; ; ;; ; ;
jhJf;fspd; epiy ; ;; ;; ;
ghjpg;G;;; /,ay;G;;;  
rhuk;;;; 
cliyAk;> kdijAk; Cf;FKwr; 
nra;tJ 
ghjpg;G - Njhy; 
RuRug;giljy; 
nre;ePH; P; P; P  
mwpT> td;ik> xsp> nrUf;F> xyp 
,itfis epiyf;fr; nra;tJ 
ghjpg;G – twl;rp 
Cz;;;; 
clypd; cUtj;ij mjd; 




xt;NthH cWg;Gk; jj;jk; nraiy 
,aw;Wk; nghOJ fbdkpd;wp ,aq;f 
mtw;wpw;F nea;g;Gg;gir Cl;b 
cjtpGhptJ. 




cliy xOq;Fgl epWj;jp itj;jy;> 
nkd;ikahd cWg;Gfisg; ghJfhj;jy;> 
cly; mirtpw;F mbg;gilahapUj;jy; 
Mfpa njhopy;fisg; GhptjhFk;. 
,ay;G 
%is 
vd;Gf;Fs; epiwe;J mitfSf;F 
td;ikAk; nkd;ikAk; jUtJ. 
,ay;G 
Rf;fpyk;; ;; ;; ; 
/RNuhzpjk;;;; 
jd;idnahj;j cUtg; ngUf;fpw;F 





Kf;Fw;wq;fSk; gUtf; fhyq;fSk;; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; 
jd;dpiy tsh;r;rp:; ; ;; ; ;; ; ;  
 Kf;Fw;wq;fSk; jj;jk; ,lq;fspy; tsh;r;rpailtNj jd;dpiy 
tsh;r;rpahFk;. 
 
Ntw;Wepiy tsh;r;rp:; ; ;; ; ;; ; ;  
 tsh;r;rpaile;j Kf;Fw;wq;fs; jj;jk; ,lk; tpl;L kPwp 
Ntw;wplq;fspw; guTkhapd; mJ Ntw;Wepiy tsh;r;rpahFk;. 
 
fhHfhyk;  - Mtzp> Gul;lhrp  
$jph;fhyk;  - Ig;grp> fhHj;jpif 
Kd;gdpfhyk; - khHfop> ij  
gpd;gdpfhyk; - khrp> gq;Fdp  
,sNtdpy; fhyk; - rpj;jpiu> itfhrp  
KJNtdpy; fhyk; - Mdp> Mb   
 
 thjkhdJ KJNtdpy; gUtj;jpy; jd;dpiy tsh;r;rpAk;> 
fhHfhyj;jpy; Ntw;Wepiy tsh;r;rpAk;> $jph;fhyj;jpy; jd;dpiyAk; 
milfpd;wJ. 
 
 moyhdJ fhHfhyj;jpy; jd;dpiy tsh;r;rpAk;> $jph;fhyj;jpy; 
Ntw;Wepiy tsh;r;rpAk;> Kd;gdpf;fhyj;jpy; jd;dpiyAk; milfpd;wJ. 
 
 IakhdJ gpd;gdpf; fhyj;jpy; jd;dpiy tsh;r;rpAk;> ,sNtdpy; 
fhyj;jpy; Ntw;Wepiy tsh;r;rpAk;> KJNtdpy; fhyj;jpy; jd;dpiyAk; 




 gpzpawp Kiwik vd;gJ cliyg; gpzpj;jyhfpa Nehiaj; 
njhpe;Jnfhs;Sfpw xOf;fk; vdg;gLk;.  ,J %tiffis nfhz;L 
mwpag;gLk;. 




nghwpahw;Nwh;jy;; ; ;; ; ;; ; ; 
• %f;F;;;   - ,ay;G 
• eh  - ,ay;G 
• fz;;;;  - ,ay;G 
• Njhy;;;;  - ghjpg;gile;J Gz;> jbg;G>  
ntbg;G> ePHf;frpTld; fhzy; 
• nrtp  - ,ay;G 
 
Gydhwpjy;;;; 
• ehw;wk;; ;; ;; ; - ,ay;G 
• Rit  - ,ay;G 
• xsp  - ,ay;G 
• CW  - ghjpg;gile;J jpkph;> jpdT> nrhwpAld; fhzy; 
• Xir  - ,ay;G 
 24 
tpdhjy;;;; 
 gpzpAw;Nwhdplj;J cs;s nghwp> Gyd;fs; gpzpfis 
njspthAzh;j;Jkhifahy;> kUj;Jtd; jd;id Nehf;fp te;j 
gpzpAw;wtidg; gw;wp mwpa Ntz;batw;iw mwpe;Jk;> jd; nghwp> 
Gyd;fshy; gpzpahsDila nghwp> Gyd; topaha; czh;tijf; Nfl;L 
mwpe;J nfhs;s Ntz;Lk;. 
 
vz; tifj; Njh;T; ; ;; ; ;; ; ;  
 “ehbg;ghprk; ehepwk; nkhoptpop; ; ;; ; ;; ; ;  
 kyk; %j;jpukpit kUj;JtuhAjk;; ; ; ;; ; ; ;; ; ; ;” 
 




 eh khrw;W cs;sjh> kh gbe;J cs;sjh mjd; epwk; Mfpatw;iw 




 ghy fug;ghd; gpzpapy; Njhypd; epwkhdJ ghjpg;gile;J rpte;j 
epwkhfNth my;yJ fUik epwkhfNth fhzg;gLfpd;wJ. 
 25 
nkhop 
 Nehahsp NgRk; NghJ rk xyp> fgj;NjhL $ba Ngr;R cuj;j 




 fz; ntspwy;> rptj;jy; Nghd;w FwpFzq;fis Muha;tjhFk;.  
ghy fug;ghdpy; tpop ,ay;ghf cs;sJ. 
 
kyk;;;; 
 kyj;jpd; jd;ikia mwpjyhFk;.  ghy fug;ghd; gpzpapy; 
thjkhdJ ghjpf;fg;gl;Ls;sjhy; kyf;fl;L fhzg;gLfpd;wJ. 
 
ePHPPP  
 “te;j ePHf;fhp vil kzk; Eiu vQ;rnyd;; P ; ; ; ;; P ; ; ; ;; P ; ; ; ; 
 iwe;jpaYstit aiwFJ KiwNa;;; ” 
 
 vd;gjd; gb ,opfpd;w ePUf;F 1. epwk; 2. vil 3. ehw;wk;                
4. Eiu 5. vQ;ry; vd Ie;J ,ay;fs; cz;L. 
 
1. epwk;;;;  : ePhpd; epwj;ij mwpjy; Ntz;Lk;.  ghy fug;ghdpy;  
  ePhpd; epwk; ,skQ;rs;. 
2. kzk;;;;  : ePhpd; kzj;ij mwpjy; Ntz;Lk;. 
3. vil  : ePhpd; vilia mwpjy; Ntz;Lk; 
4. Eiu  : Eiu cs;sjh vd;W mwpjy; Ntz;Lk; 
5. vQ;ry;; ;; ;; ; : ePH mstpy; Fiwjy; my;yJ kpFjy; ,tw;iw  
 mwpjy; Ntz;Lk;. 
 26 
nea;;;;f;Fwp; ;; ;; ;   
  ePH epwf;Fwpahy; Nehiaf; fz;L gpbj;jw; nghUl;Lr; 
nrhy;ypapUf;fpd;w tpjp nghUe;jpa rpWePhpy; xU rpwpa Jsp vz;nzia 
eLtpy; ifairtpdhy; vz;nza;j; Jsp rpjwhky; tpl;L nta;apyhdJ 
me;ePhpy; gLk;gb jpwe;J fhw;whdJ mjpy; tPrp me;j vz;nza;j; Jsp 
Mlhjgb itj;J mr;rpWePhpy; tplg;gl;bUf;fp;d;w vz;nza;j; JspahdJ 
nry;Yfpd;w topapy; fz;zwpitAk;> capuwpitAk; nrYj;jp mj;Jsp 
njhptpf;Fk; Neha; tpsf;fj;ij mwpjy; Ntz;Lk;. 
 
 
ghy fug;ghd; Nuhfj;jpy; nea;f;Fwp; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
“muntd ePz;bbw; m/Nj thjk;P ; ; ;P ; ; ;P ; ; ;” 
 
  vz;nza; Jsp tpl;lgpd; mJ ghk;G Nghd;W ePSkhapd; m/J thj 
Nehapidf; fhl;Lk; nea;f;FwpahFk;. 
 “Mop Nghy;gutpd; m/Nj gpj;jk;; ; ; ;; ; ; ;; ; ; ;” 
 vz;nza; Jsp tpl;lgpd; mJ Nkhjpuk; Nghd;W guTkhapd; m/J 
gpj;j Nehapidf; fhl;Lk; nea;f;FwpahFk 
 
 “Kj;njhj;J epw;fpd; nkhoptnjd; fgNk; ; ; ; ;; ; ; ; ;; ; ; ; ; ” 
 
  vz;nza;j; Jsp tpl;lJ tpl;lthNw rpwpJk; guthky; Kj;Jg;Nghy; 
epd;wJ.  Ia Nehapidf; fhl;Lk; nea;f;FwpahFk;.   
 27 
ehb: 
 “rpwg;ghd thjj;jp Yl;bze; jhNd; ; ; ;; ; ; ;; ; ; ;  
  Nrh;e;jpL fpyjprhu Kisr;ry; thA; ; ; ;; ; ; ;; ; ; ;  
 ciug;ghd nghUknyhL mf;fpdp ke;jk;; ; ; ;; ; ; ;; ; ; ; 
  cs;shFk; ePHr;rpwg;G gpuNkfq;fs;; ; P ; ; ; ;; ; P ; ; ; ;; ; P ; ; ; ; 
 gpwg;ghL kjfhp ePH fug;ghd; uj;jk;.......; P ; ; ; ;; P ; ; ; ;; P ; ; ; ; ” 
       - rjf ehb 
 
 thj ehbahdJ kpFjpaile;J mjDld; c\;zKk; Nrh;e;jhy; 
fug;ghd; Nehapid cz;lhfpd;wJ. 
 
 “jhdKs;s Nrj;Jke;jhdpsfpy; ntg;G; ; ; ; ;; ; ; ; ;; ; ; ; ;  
  rakPis ,Uky; ke;jhu fhrk;P ; ; ;P ; ; ;P ; ; ; 
 <dKWQ;re;jp tplNjhlk; tpf;fy;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
  ,Uj;Nuhfq; fug;ghd; tpuz Njhlk;....; ; ; ; ;; ; ; ; ;; ; ; ; ; ” 
 
  Nrj;Jkk; ehb jd;dstpy; ,Ue;J mjpfhpj;Jf; fhZk; NghJ 
fug;ghd; Neha; cz;lhfpd;wJ. 
 
ghprk;:;;;  
 ghy fug;ghd; gpzpapy; ];ghprk; ghjpg;gile;J RuRug;Gld; ePH 
girapd;wp jpkph;> jpdT> nrhwp> Gz;> jbg;G ntbg;G> ePH tbjy;> Njhypy; 
epwkhw;wk; Mfpa FwpFzq;fSld; fhzg;gLfpd;wJ. 
 28 
kUj;Jtk;:; ;; ;; ;  
 Neha; Njhd;Wtjw;fhd fhuzq;fisf; fz;lwpe;J mjw;Fhpa 
rpfpr;ir Kiwia gj;jpaj;Jld; filg;gpbj;J> Neha; tuhky; 
jLg;gjw;Fhpa Kiwiaf; ifahStNj rpj;j kUj;Jtj;jpd; rpwg;ghd 
nfhs;if MFk;.  ,J %d;W gphpTfSs; mlq;Fk;. 
1. fhg;G;;;  
2. ePf;fk;P ; ;P ; ;P ; ; 
3. epiwT. 
fhg;G:;;;  
 rpj;j kUj;Jt Kiwapy; fhg;G vd;gJ Kjd;ikahd xd;whFk;.  
Neha; Njhd;Wtjw;F fhuzkhdtw;iw jLj;J MAis ePbf;fr; nra;tNj 
fhg;ghFk;.   
 
ePf;fk;:P ; ;P ; ;P ; ;  
 cliy fhg;gjw;Fhpa newpfis filg;gpbj;J elf;fj; 
jtWthdhapd; tsp> moy;> Ia Fw;wq;fspdhy; cz;lhd Neha;fshy; 
Jd;gkilthd;. mq;qdk; tUtpj;Jf; nfhz;l gpzpfisg; Nghf;Fk; 
tpjpfNs ePf;fk; vdg;gLk;.  gpzpahdJ Kf;Fw;wq;fis jd;dpiyf;Ff; 
nfhz;L tUtjd; %yk; ePf;fg;gLfpd;wJ. 
 
 29 
kUj;Jt Kiw: ;;;  
 
• ghyfug;ghd; gpzpapy; ,Wjpapy; gpj;j Fw;w tpfhuKw;W 
Neha;f;FwpFzq;fs; kpFjpg;gLtjhy; mij Kjyhf 
jd;dpiyailar; nra;J gpd; tpfhuKw;w thj> fgf; Fw;wq;fis 
jd;dpiyg;gLj;Jk; kUe;Jfis toq;Fjy; Ntz;Lk;. 
• thjf;Fw;wj;jpdhy; vOe;j kyf;fl;bid rPHnra;a kykpsf;fp 
kUe;Jfis toq;Fjy; Ntz;Lk;. 
• VO clw;fl;LfisAk; td;ikgLj;Jk; kUe;Jfis toq;Fjy;.  
kUj;Jt mwpTiu;;;  
• Fspg;gjw;F ghrpg;gaW khT> eYq;F khtpid cgNahfg;gLj;j 
Ntz;Lk;. 
• jphpgyh #uzj;jpid FbePuhf;fp Neha;fz;l ,lj;jpid ed;F 
fOtp> Jilj;J gpd; ed;dhhp Nth; vz;nzapid ntspg;G+r;rhf 
gad;gLj;Jjy; Ntz;Lk;. 
• gj;jpa> mgj;jpa czTg; nghUl;fis mwpe;J czT Kiwia 






mgj;jpa cz;;; T Kiwfs;;;; 
 
 mfj;jpAld; G+rzpf;fha; Glyq;fhAk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
  kd;ghd thiof; fhAz;zhHfs;; ; ; ;; ; ; ;; ; ; ; 
 epfo;j;jpa kPd; fLFld;ntq; fhaq;$l;b; ; P ; ; ; ; ;; ; P ; ; ; ; ;; ; P ; ; ; ; ;  
  epj;jpaNk jpd;dJz;lhy; nebNahdhfhd;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
 nrfj;jpy; epd;w tiuf;fPiu tWf;if khq;fha;; ; ; ; P ; ; ;; ; ; ; P ; ; ;; ; ; ; P ; ; ; 
  jpfl;lhj fj;jhpf;fha; jPdghHf; fha;; ; ; ; P ; ;; ; ; ; P ; ;; ; ; ; P ; ; 
 kfj;Jtkhq; Fk;gKdp aUspr; nra;j; ; ; ; ;; ; ; ; ;; ; ; ; ;  
  khwhj nrhwp gwq;fptsU nkd;Nw.; ;; ;; ;  
 
  mfj;jpf;fPiu> G+rzpf;fha;> Glyq;fha;> thiof;fha;> kPd;> fLF> 
ntq;fhak;> miuf;fPiu> khq;fha;> fj;jhpf;fha; Nghd;wtw;iw cztpy; 
Nrh;j;Jf;  nfhs;Sk;NghJ fug;ghd; gpzp kpFjpg;gLtjhy; ,itfis 




 Nehahspia rpj;j kUj;Jt Kiwapy; ghpNrhjpj;J Nehapidg; 
gw;wpa njspthd tpsf;fj;jpidAk;> kUe;Jz;Zk; NghJ filg;gpbf;f 
Ntz;ba tpjpKiwfisAk; nfhz;L Nehapidj; jPhg;gNj epiwthFk;. 
 
 ghy fug;ghd; gpzpf;F gy E}y;fspy; gw;gy kUe;Jfs; 
$wg;gl;Ls;sd. ,Ug;gpDk; Ma;thsh; jdJ Ma;tpw;fhf ed;dhhp Nth; 
vz;nzapid Njh;e;njLj;Js;shH. 
 
 xU %ypifapd; Nth;> jz;L> fl;il> gl;il> ,iy> kyh;> fdp> 
tpij Mfpa midj;J cWg;GfSNk kUj;Jtj; jd;ik 
tha;e;jitahk;.  MdhYk; ,it midj;jpYk; Nth;jhd; mjpfkhd 
kUe;Jr; rj;Jfis Nrkpj;J itf;fpd;wJ. Nth;fspy; ,iy Nghd;w 
mikg;Gfs; ,y;yhjjhy; ,iy cjph;jy; Nghd;w epfo;r;rpfs; %yk; 
kUe;Jr; rj;Jfs; ntspNawhky; jtph;f;fg;gl;L NthpNyNa Nrkpj;J 
itf;fg;gLfpd;wd.  
 
  ed;dhhp Nth; vz;nza;apy; cs;s VO ruf;FfSk; Nth;fshFk;.  
G+z;L jiuf;fPo;j;jz;L MFk;. Ma;tpw;fhd kUe;jhdJ 
kUe;Jr;rj;Jfis mjpfk; nfhz;l jd;ikAk; vspjpy; 
fpilf;ff;$bajhfTk; ,Ug;gjhy; “ed;dhhp Nth; vz;nza;” ahdJ ghy 






  ECZEMA is a  non-contagious inflammation of the skin, 
characterised by erythema, scaling, oedema, vesiculation and oozing.  It is a 
specific type of allergic cutaneous manifestation of antigen-antibody 
reaction.   The term ECZEMA is a greek word.  ‘EC’ means - out, ‘Zeo’ 
means – boil. 
 
CLASSIFICATION OF ECZEMA 
  Classification divides into two groups. 
1. Exogenous eczema 
2. Endogenous eczema 
 
  Exogenous eczemas are related to external trigger factors, although 
inherited tendencies also play a part. 
 
 Endogenous eczema implies that the eczematous condition is not a 
result of exogenous or external environmental factors, but is mediated by 
processes originating within the body. 
 




 Atopic eczema, Besnier’s prurigo. 
 
INTRODUCTION: 
 Atopy is derived from a greek word atopos, meaning out of place.  
The term atopy was coined by coca and cooke.  The disease was named as 
‘atopic dermatitis by sulzberger and associates.  Besnier in 1892 described 
the association of hay fever and asthma with Atopic Dermatitis. 
 
DEFINITION: 
 ATOPIC DERMATITIS is an acute, subacute or chronic relapsing, 
endogenous eczema characteized by dry skin and pruritic, recurrent, 
symmetric, dermatic lesions. 
 
ETIOPATHOGENESIS 
 Various etiological factors implicated in the pathogenesis of AD are 
1. Heriditary factors 
2. Environmental factors 
3. Immunodysregulation 
4. Infectious agents 
5. Psychological factors 
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1. Heriditary  factors 
  Afamily history of ‘atopy’ can be obtained in approximately 43-73% 
of the cases with AD. 
 
2. Environmental factors 
 Atopic dermatitis is supposed to be more common in urban than rural 
set up.  This is probably because of industrialization and changed lifestyle.  
In general AD is known to aggravate during winter.  However, heat and 
exercise induced sweating can increase the puritus of AD. 
 
3. Immunodysregulation 
 AD is a complex genetic disorder that results in a defective skin 
barrier, reduced skin innate immune response and exaggerated T cell 
responses to environmental allergens and microbes that lead to chronic skin 
inflammation. 
 
4. Infectious agents. 
 The increased incidence of carriage state of staphylococcal aureus in 
both involved and uninvolved skin in patients with AD. 
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5. Psychological factors 
 AD has a tremendous psychological effect on various aspects of life of 
an affected individual.  In children it has been found that a hyper-responsive 
hypothalamic pituitary-axis (HPA) blunts the body’s capability to produce 
cortisol during the period of stress.  The resultant inability to suppress 
inflammatory response leads to aggravation of the eczema.  The children 
suffering from AD usually have  swinging mood with frequent fluctuations.  
Menarche often precipitates AD for the first-time. 
 
SKIN ANATOMY 
 Skin is composed of a superficial epithelial layer the epidermis and   
an underlying connective tissue layer the dermis.  Beneath the dermis is 
another connective tissue layer hypodermis.  Main layers of the epidermis 
are stratum germinativum, stratum malpighi, stratum granulosum, stratum 















 Acute skin lesions are characterized by spongiosis or marked 
intercellular oedema of the epidermis.  In chronic skin lesions 
hyperkeratosis, acanthosis and infiltration of upper dermis with lymphocytes 
are seen. 
 AD have a defect in the gene coding for filaggrin, a protein essential 
for maintaining the barrier function of the stratum corneum.  The stratum 
corneum then allows various irritans to penetrate the skin surface, elicit 
cytokine release from keratinocytes and initiate a Th 2 immune response 
acutely that leads to the clinical response acutely that leads to the clinical 
manifestations of disease and increased IgE levels. 
 
CLINICAL FEATURES 
 Atopic Dermatitis is the most common chronic relapsing skin disease 
seen in infancy and childhood.  Infants with AD are predisposed to 
developing allergic rhinitis and/or asthma later in childhood the so called 
“atopic march”. 
 
 AD may present at any age, but 60% of patients experience their first 




 Acute skin lesions are intensely pruritic with erythematous papules. 
 Subacute dermatitis is characterized by erythematous, excoriated, 
scaling papules. 
 Chronic AD is characterized by lichenification or thickening of the 
skin with accentuated surface markings and fibrotic papules. 
 Three clinical phases are recognized. 
INFANTILE PHASE 
AGE   :  2 months to 2 years 
DISTRIBUTION :   Cheeks, face and scalp, extensor surfaces of  
extremities and trunk. 
 The lesions consists of erythema and discrete or confluent oedematous 
papules.  The papules are intensely itchy and may become exudative and 
crusted as a result of rubbing.  Secondary infection and lymadenopathy are 
common.  The disease runs a chronic fluctuating course, varying with such 




AGE   :  3 to 11 years 
DISTRIBUTION :  Wrists, ankles, backs of thighs, buttocks and  
anticubital and popliteal fossae. 
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 The sides of the neck may show a striking reticulate pigmentation, 
some times referred to as “atopic dirty neck”. 
 
 The anatomical basis for this distribution in unknown.  Sometimes 
only one site is involved.  The erythematous and oedematous papules tends 
to be replaced by lichenification.  Some patients with AD are apparently 
unable to lichenify, even after prolonged rubbing. 
 
 Patients with an extensor distribution of eczema in later childhood are 
uncommon.  As well as the typical mixture of papules and lichenification 
true eczematous lesions with vesiculation may occur often with exudative 
lesions and some times with nail changes.  Acute generalized or localized 




Young adult 12 to 20 years 
Distribution : face, neck, arms, back and flexures. 
Morphology : Thick, dry, lichenified plaques without weeping  
  or oozing. 
Adult > 20 years 
Distribution : Most commonly involves the hands sometimes  
   the face and neck rarely diffuse areas. 
Morphology : Lichenified plaques, fissures on the hands  
  occasional vesicular outbreaks.  
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ATOPIC HAND ECZEMA 
 A more diffuse chronic lichenified eczema of the hands is frequently 
found in cases of extensive atopic dermatitis which persist into adult life.  
Involment of feet is also common.  The nails are often involved. 
 
OTHER MANIFESTATIONS IN AD: 
  Allergic rhinitis and asthma occur in 30-50% of AD.  
 
  Dry skin is a common feature of AD because of increased 
transpidermal water loss through an abnormal stratum corneum. 
 
DIAGNOSIS:  
  There is no laboratory gold standard for the diagnosis of AD.                       
A detailed history and a characteristic clinical picture would establish the 
diagnosis. 
 
HANIFIN AND RAJKA’S CRITERIA FOR DIAGNOSIS OF AD. 
 Hanifin and Rajka proposed a systemic approach towards the 
standardization if the diagnosis of AD by incorporating 3 major and 23 
minor features.  They suggested  that the diagnosis of AD can be established 
if 3 of the major and 3 of the minor criteria are present. 
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Major features for the diagnosis of AD. 
1. Pruritus. 
2. Typical morphology and distribution: flexural lichenification or  
     linearity in adults, facial and extensor involvement in infants and  
     children. 
3. Chronic or chronically relapsing dermatitis. 
4. Personal or family history of atopy (asthma, allergic rhinitis, AD)  
 
Minor characteristic features for the diagnosis of AD 
1. Xerosis 
2. Icthyosis/Palmar hyperlinarity/Keratosis pilaris 
3. Immediate (type 1) skin test reactivity 
4. Elevated serum IgE 
5. Early age at onset 
6. Tendency towards cutaneous infections (staphylococcus aureus and  
     herpes simplex,  group A streptococcus, vaccinia,  
     Molluscum, warts) Impaired cell mediated immunity. 
7. Tendency towards nonspecific hand or foot dermatitis. 
8. Nipple eczema 
9. Cheilitis 
10. Recurrent conjunctivitis 
11. Dennie-Morgan infraorbital folds 
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12. Keratoconus 
13. Anterior subcapsular cataracts 
14. Orbital darkening 
15. Facial pallor/facial erythema 
16. Pityriasis alba. 
17. Anterior neck folds 
18. Itch when sweating 
19. Intolerance to wool or lipid solvents 
20. Perifollicular accentuation 
21. Food intolerance 
22. Course influenced by environmental/emotional factors 




Most patients with AD have peripheral blood eosinophilia and 
increased serum IgE levels.  Specific IgE antibodies against environmental 
antigens can be detected in most patients with AD.  
Children with associated respiratory atopy have up to 100% positive 






• Seborrheic dermatitis 
• Contact dermatitis 




• Hyper IgE syndrome 
• Dermatitis herpetiformis 
• Zinc  deficiency 
• Vitamin B6 and Niacin deficiency 
 
FACTORS PROVOKE OR EXACERBATE ATOPIC DERMATITIS 
Irritants: 
• Wool clothing the size of wool fibers stimulates intense itching via 
allokinesis.  
• Soaps, especially with high PH. 
• Clothing made of blenced or synthetic fabrics and shirt collar tags. 
• Climate extremes- heat, cold, low humidity and high humidity. 
Infections 
 Staphyloccocus aureus colonizing skin releases superantigens that 




 Exacerbation of AD can occur after intranasal or epicutaneous 
exposure to aeroallergens such as fungi, animal dander, grass or ragweed 
pollen.  Dust mite allergens from pillows, mattresses and box springs. 
 
Foods 
In susceptible individuals exposed to certain allergens, food specific 
IgE antibodies are formed, bind to mast cells, basophils and macrophages 
leading to pharmacologically active histamine, serotonin like substances 
induce hypersensitive reaction.  Cytokines that  leads to a delayed more 
chronic inflammatory process affecting the skin, mixed IgE and cellular 
responses to food allergens can also lead to AD. 
 
 Children developing IgE-mediated food allergies may be sensitized by 
food allergens penetrating the gastrointestinal barrier, which are class I food 
allergens, or by partially homologous allergens such as plant pollens 
penetrating the respiratory tract, which are class 2 food allergens. 1/3 of 
children with moderate to severe atopic dermatitis  have food allergies. 
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Major Food Allergens. 
CLASS I 
Food      -  Protein  
Cow’s milk      -  Casein, β-lactoglobulin  
Egg      - Ovomucoid  
Peanut      - Vicilin, conglutin  
Fish      - Paralbumin  
 
CLASS II   
POLLEN  CROSS-REACTING FOOD 




Ragweed  Watermelon 
Honeydew 
 
Cross reacting protein in IgE mediated reaction 
 Legumes  - peanut, soya, lentil, lupine and garbanzo  
Mammalian milks - cow’s milk, Goat’s milk 
Latex food  - Banana 
Walnut , Rosaceae fruits, Grains, Fish and Shell fish 
  
Exposure and sensitization to these proteins often occur very early in 
life, because intact food proteins are passed to the infant through maternal 
brest milk and after introduction of solid foods, many parents strive to 
provide their infant with a highly varied diet. 
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COMPLICATIONS 
• Staphylococcal aureus is found in >90% of AD skin lesions 
honey coloured crusting, folliculitis, impetigo and pyoderma are 
indications of staphylococal aureus. 
• Kaposi’s varicelliform eruptions from disseminated herpes 
infection. 
• Extensive Molluscum contagiosum lesions 
• Extensive verruca vulgaris or common warts 
• Disseminated dermatophytic infections 
• Disseminated candidal infections 
• Patients with extensive skin involvement may develop exfoliative 
dermatitis 
• Atopic keratocojunctivitis 
• Keratoconus is a conical deformity of the cornea 
• Various psychological complications. 
 
PROGNOSIS 
 The disease follows a stepwise reduction in the severity over next    
10-12 years and by 12-15 years it heals completely.  Many children or 
individual probably relapse at some stage in adulthood either in the form of 
irritant hand eczema or pompholyx or dyshidrotic eczema of the hands. 
Factors which may indicate a poor prognosis include severe childhood 
disease, early onset and concomitant family history of asthma/hay fever. 
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MANAGEMENT OF AD 
• Avoid provoking factors (scrubbing, bathing> 10 minutes, hot water 
bathing, scented soaps, irritating cloting, low humidity, temperature 
extremes, copious sweating etc.) 
• Avoid contact with irritants like wollens, chemicals. 
• Using mild soaps and cleansing lotions 
• Avoiding house dust mite.  Avoidance measures include use of dust 
mite-proof encasings on pillows, mattresses and box springs, washing 
beddings in hot water weekly, removal of bedroom carpeting. 
• The normal diet may be given, but if certain foodstuffs constantly 
aggravate the skin condition, that should be omitted.  Diet diary is 
useful, every foodstuffs taken during the day is marked and at the 
bottom of the column the patient puts down whether  he felt better or 
worse or suffered from an acute flareup. 
• Healthy hobbies and play should be encouraged. 
• Counseling and psychotherapy.  Reassuring the patient and his 
relatives that the disease curable, non-infectious and non-scarring. 
• Palliative treatment must be proper carried out to effect a complete 
cure. 
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MATERIALS AND METHODS 
 The study on clinical evaluation of the disease Balakarappan was 
carried out in the post-Graduate Kuzhanthai Maruthuvam Department at 
Government Siddha Medical college, Palayamkottai.  Fifty patients were 
selected for the study and 20 patients were admitted in the post-graduate 
Kuzhanthai Maruthuvam ward.  After discharge of these in patients all of 
them were followed as out patients in the out patient department. 
 
Selection of Patients 
 The present study covers both male and female patients between the 
age group of 6  months- 12 years.  All the cases were carefully examined for 
correct diagnosis and rule out any other coexisting illness. All the patients 
were diagnosed using questionaire and indivudual case sheet was maintained 
for each and every in patients. 
 
Study of Siddha clinical diagnosis 
 The history of dietetic habits, allergic details and the nilam from 
which they come were also noted.  Paruva kaalam at which the disease 
occured is noted.  In vatha kutram the types of pranan, Abaanan, Viyanan, 
Udhanan, Samanan, Naagan, Koorman, Kirugaran, Devathathan, 
Thananjeyan were noted. 
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 In pitha kutram the states of anelam, Ranjagam, Sathagam, Alosagam, 
Pirasagam were noted.  In kabha kutram Avalambagam, Kilethagam, 
pothagam, Tharpagam, Sandhigam were noted.  Envagai thervugal and Ezhu 




Modern diagnostic tests 
Blood Urine  Motion 
TC  Albumin ova 
DC  Sugar  cyst 
ESR  Deposits  
Hb% 
Specific investigations 
 Skin prick test for IgE. 
 Specific IgE antibody test 
 Radio allergen sorbent assay (RAST) 
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 Pharmacological evaluation of the  drugs were conducted by the 
pharmacology department of Government Siddha Medical College, 
Palayamkottai. 
 
 Biochemical analysis of the drugs were conducted by the 




 “Nannari ver ennai” Internally given for all fifty patients.  The dose 
is adjusted to age of the patient.  Externally “Nannari ver ennai” was applied 
and clinical improvements in the patients were noted with the reducing 
clinical symptoms and the available laboratory tests.  Pathiyam, diet control 
strictly followed for all.          
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RESULTS AND OBSERVATIONS 




4. Economic status of the patient 
5. Diet 
6. Family history 
7. Paruva kaalam 
8. Mode of onset 
9. Clinical features of Balakarappan during admission 
10. Three dosha theory 
11. Ezhu udarkattugal 
12. Envagai thervugal 
13. Neerkuri, Neikuri 
14. Etiology 
15. Results after treatment 
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GENDER DISTRIBUTION 
Incidence of sex among the patients with bala karappan 
 
S.No. Sex Number of cases Percentage (%) 
1 Male 27 54 































AGE AMONG THE PATIENTS WITH BALAKARAPPAN 
 
S.No. Age Number of cases Percentage (%) 
1 6 months – 1 year 4 8 
2 1-3 years 16 32 
3 3-6 years 15 30 















6 months – 1
year
















 In 50 Patients 8% were 6 months – 1year, 32% were 1-3 years, 30% 
were 4-6 years, 30% of cases were 7-12 years.  
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RELIGION AMONG THE PATIENTS IN BALAKARAPPAN 
 
S.No. Religion Number of cases Percentage (%) 
1. Hindu 40 80 
2. Christian 3 6 


























 In 50 of cases , 80% of cases were Hindu, 6% were christian,                  
14% were muslim. 
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 In 50 of patients, 62% of cases were poor, 36% of cases were middle, 
2% were rich. 
S.No. Socio economic status Number of cases Percentage (%) 
1 Lower income groups 31 62 
2 Middle income groups 18 36 
3. High income groups 1 2 
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S.No. Diet habit Number of cases Percentage (%) 
1 Vegetarian 2 4 
2 Mixed diet 48 96 
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 Out of 50 Patients 62% of cases had positive family history, 38% had 
negative family history. 
 
S.No. Family history Number of cases Percentage (%) 
1 Positive 31 62 
2 Negative 19 38 
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DISTRIBUTION OF ETIOLOGY OF PATIENTS IN BALA KARAPPAN 
S.No. Etiology Number of cases Percentage (%) 
1 Aero allergens 7 14 
2 Positive family history 31 62 












  Out of 50 patients aero allergens sensitivity was seen in  14 of cases, 
positive family history was seen in  62% of cases , food allergens sensitivity 




S.No. Paruva kaalam Number of cases Percentage (%) 
1. 
Kaar 




































































































































































 According to paruva kaalam high incidence of  56% cases were noted 
in koothir kaalam.  In kaar kaalam  20%, Elavenil kaalam 10%, Munpani 
kaalam 6%, Muduvenil kaalam 6%, pinpani kaalam 2% were noted. 
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  Out of 50 cases 94% of cases had chronic onset of symptoms, 6 % of 
cases were had acute onset of symptoms. 
S.No. Mode of onset Number of cases Percentage (%) 
1 Acute 3 6 
2 Chronic 47 94 
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S.No. Clinical features Number of cases Percentage 
1 Itching 50 100 
2 Erythema 15 30 
3 Papules 50 100 
4 Oedema 3 6 
5 Vesicles 45 90 
6 Oozing 45 90 
7 Excoriation 45 90 
8 Crusting 45 90 
9 Pustules 2 4 
10 Scaling 10 20 
11 Xerosis 17 34 
12 Lichenification 25 50 



























































































































  Among 50 cases  100 % of the patients had Itching,  30%  had 
erythema, 100% of patients were had papules,  oedema seen in 6% of cases, 
vesicles, Oozing, excoriation and crusting were seen in  90% of cases, 4% 
were had  pustules,  20% of patients had scaling, 34% of patients had 




DISTRIBUTION OF PATIENTS WITH BALAKARAPPAN                             




































































































 According to vali, derangement of viyanan, uthanan and samanan 
was 100%, Devadhathan was deranged in 60%, Abaanan was deranged in 
56% of cases 
 
S.No. Classification of vatham Number of cases Percentage (%) 
1 Piranan - - 
2 Abaanan 28 56 
3 Viyanan 50 100 
4 Uthanan 50 100 
5 Samaanan 50 100 
6 Naagan - - 
7 Koorman - - 
8 Kirukaran - - 
9 Devathathan 30 60 
10 Thananjeyan - - 
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DISTRIBUTION OF PATIENTS WITH BALAKARAPPAN                                
ACCORDING TO PITHAM 
S.No. Classification of Pitham Number of cases Percentage (%) 
1 Anal pitham 20 40 
2 Ranjagam - - 
3 Sathagam - - 
4 Prasagam 50 100 


































































 According to pitham derangement of prasagam was 100% and 
derangement of Anal pitham was 40% 
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DISTRIBUTION OF PATIENTS WITH BALAKARAPPAN                              






































































 According to Iyyam, Kilethagam was affected in 67% if cases. 
 
S.No. Classification of kabam Number of cases Percentage (%) 
1 Avalambagam - - 
2 Kilethagam 28 67 
3 Pothagam - - 
4 Tharpagam - - 
5 Santhigam - - 
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 Saaram, senneer, kozhuppu was affected in 100% of cases. 
S.No. Ezhu udarkattugal Number of cases Percentage (%) 
1 Saaram 50 100 
2 Senneer 50 100 
3 Oon - - 
4 Kozhuppu 50 100 
5 Enbu - - 
6 Moolai - - 
7 Sukkilam/Suronitham - - 
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 In naadi vatha pitham was observed in 54% of cases, vatha kabam was 
observed in 10% of cases, pitha vatham was observed in 36% of cases, 
derangement of niram and sparisam were observed in 100% of cases,  malam 
erugal was observed in 56% of cases. 
S.No. Envagai thervugal Number of cases Percentage 
1 Naadi   
 Vathapitham 27 54 
 Vatha kabam 5 10 
 Pitha vatham 18 36 
2 Sparisam 50 100 
3 Naa - - 
4 Niram 50 100 
5 Mozhi - - 
6 Vizhi - - 
7 Malam 28 56 
8 Moothiram - - 
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NEERKURI OF PATIENTS WITH BALAKARAPPAN 
 
NEIKURI OF PATIENTS WITH BALAKARAPPAN 
S.No. Neikuri Number of cases Percentage 
1 “Aravena Neelal” – Vatham 19 38 
2. “Azhipol paraval”– Pitham 15 30 

















































































 Neerkuri-Vaikkol Niram was observed in 100% of cases. 
 Neikuri – According to Neikuri, Vatha neer was observed in 38% of 
cases, pitha neer was observed in 30% of cases, kabha neer was observed in 
32% of cases. 














































 Out of 50 patients, 72% of cases showed significant improvement.    
24% of cases were showed Moderate improvement and 4% of cases showed 
mild improvement. 
S.No. RESULTS Number of cases 
Percentage 
(%) 
1. Good  36 72 
2. Moderate 12 24 
3. Mild 2 4 
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date    IP  OP 
Result 
1. 2398 Abisha 4/FC 15 days Itching, vesicles, oozing and crusting 24/07/2012 03/08/2012 11 45 Good 
2. 2400 Kavitha 7/FC 20 days Itching, erythema, papules, vesicles, oozing, 
constipation. 
24/07/2012 27/07/2012 4 37 Good 
3. 3018 Ramya 5/FC 1 month Itching, erythema, papules, vesicles, oozing, 
crusting 
11/09/2012 17/09/2012 7 40 Good 
4. 3253 Abdulla 9/MC 1½ months Itching, vesicles, crusting and oozing with 
mild lichenificaton. 
26/09/2012 04/10/2012 9 43 Good 
5. 3276 Rasool 
Maideen 
12/MC 3 weeks Itching, vesicles with oozing, crusting, 
constipation 
27/09/2012 04/10/2012 8 42 Moderate 
6. 3296 Harini 4/FC 2 months Itching, erythema, papulo vesicles, oozing, 
constipation 
27/09/2012 05/10/2012 9 41 Good 
7. 3294 Uma 
Maheswari 
11/FC 1 month Itching, papulo vesicles. oozing with 
lichenfied scaly patches. 
27/09/2012 04/10/2012 8 38 Good 
8. 3366 Monisha 12/FC 20 days Itching, vesicles, oozing and crusting with 
mild lichenfication. 
01/10/2012 05/10/2012 5 35 Good 
9. 3389 Vikram 10/MC 1 ½ month Itching, papules, pustules, crusting, 
lichenfication, constipation 
02/10/2012 08/10/2012 7 41 Moderate 
10. 3404 Baskar 1 ½ /MC 20 days Itching, erythema, excoriation, crusting, 
mild oozing, constipation 





11. 3406 Anis charles 11/MC 1 month Itching, papulo vesicles, crusting, oozing, 
lichenified scaly patches, constipation 
03/10/2012 09/10/2012 7 43 Good 
12. 3481 Kavin 2/MC 20 days Itching, erythema, papulo vesicles, oozing, 
crusting. 
08/10/2012 16/10/2012 9 38 Good 
13. 3496 Prakash 3/MC 3 weeks Itching, erythema, papules, vesicles, oozing, 
crusting and excoriation, xerosis, 
constipation. 
09/10/2012 16/10/2012 8 37 Good 
14. 3554 Poongodi 4/FC 1 ½ months Itching, erythema, papules, vesicles, oozing, 
crusting, constipation 
12/10/2012 18/10/2012 7 41 Moderate 
15. 3573 Stella arul 
mary 
12/FC 2 months Itching, papules, pustules, oozing, 
excoriation and crusting, lichenfication 
13/10/2012 20/10/2012 8 42 Good 
16. 3574 Srinivasan 9/MC 1 month Itching, papulo vesicles, oozing, crusting, 
constipaiton 
13/10/2012 20/10/2012  39 Good 
17. 3575 Durga 12/FC 20 days Itching, papules, vesicles, oozing, mild 
lichenfication 
13/10/2012 20/10/2012  44 Good 
18. 3920 Govindamal 6/FC 1 month Itching, papulo vesicles, oozing, 
constipation 
    Moderate 
19. 3921 Muthupandi 3/MC 15 days Itching, erythema, papules, oozing, crusting     Good 
20. 3953 Dharshneem 2/FC 3 weeks Itching, erythema, oozing, papules, crusting, 
constipation. 
    Poor 
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14.ii. OUT PATIENT RECORD 
 
S.N Op.No. Name 
Age 
/Sex 








1. 51630 Akila 7m/FC 45 Good 16 80312 Manivasagam 2/MC 16 Good 
2. 54979 Manikandan 4/MC 44 Good 17 80385 Narayanan 4/MC 45 Good 
3. 56485 Vaishnavi 4/FC 40 Moderate 18 80721 Meerangani 6/MC 45 Moderate 
4. 57349 Isakkimuthu 8/MC 38 Good 19 81493 Suresh 2/MC 45 Good 
5. 60731 Mahendran 6/MC 41 Moderate 20 84048 Mithra 7/FC 41 Moderate 
6. 61085 Indhuja 12/MC 35 Good 21 85390 Sridesh 3/MC 44 Good 
7. 62163 Kalaiselvam 4/MC 40 Good 22 86804 Kathirvel 3/MC 43 Good 
8. 72450 Chandru 12/MC 45 Good 23 86470 Selvi 1/FC 18 Good 
9. 72475 Mohamad 1/MC 18 Good 24 87582 Esakkimuthu 5/MC 35 Good 
10. 76825 Ashima 2/FC 45 Moderate 25 88586 Sushmitha 8M/FC 37 Good 
11. 78602 Syed 7/MC 19 Good 26 88576 Maharaja 2/MC 17 Good 
12. 78601 Steffy 6/FC 37 Poor 27 90072 Bala mugila 6/FC 36 Moderate 
13. 78603 Vidhya mathi 5/FC 38 Moderate 28 95066 Arun 3/MC 41 Good 
14. 79568 Kannan 8/MC 45 Good 29 95067 Vigneshkumar 2 ½ /MC 39 Good 
15. 79963 Praveenkumar 3/MC 33 Good 30 97327 Haritha 3/FC 44 Moderate 
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15.  LABORATORY INVESTIGATIONS 
BT – Before Treatment,   AT -  After Treatment, P – Polymorphs,  L – Lymphocytes, E-Eosionophils,   ESR – Erythrocyte 
Sedimentation Rate, Hb - Haemoglobin A- Albumin, S – Sugar, D – Deposits,N - Nil 
i. Haematological Investigation Urine Analysis Motion Analysis 










Count cells /  
cu.mm BT AT BT AT 
Hb gm% 
A S D A S D Ova Cyst Ova Cyst 
S.No. IP.No 
Name of the 
patient 




hr 1hr BT AT 
N N N N N N N N N N 
1 
2398 Abisha 





N N N N N N N 
2 2400 Kavitha 9200 9000 61 42 5 60 40 2 10 20 5 10 8.6 10.1 N N N N N N N N N N 
3 3018 Ramya 8500 8400 59 48 7 58 47 1 8 16 7 14 9.5 11.5 N N N N N N N N N N 
4 
3253 Abdulla 



















6 3296 Harini 9200 9100 62 51 7 61 48 1 12 24 6 12 11.2 12 N N N N N N N N N N 
7 
3294 Uma 








8 3366 Monisha 8200 8100 58 42 10 56 46 2 8 16 4 8 7.5 10.2 N N N N N N N N N N 
9 3389 Vikram 8500 8300 59 40 11 58 40 4 15 30 8 16 11.2 11.4 N N N N N N N N N N 
10 3404 Baskar 9300 9100 65 52 9 63 50 2 9 18 5 10 10.1 12.3 N N N N N N N N N N 
11 3406 Anis charles 8500 8400 65 53 10 64 52 1 14 28 7 14 12.1 12.6 N N N N N N N N N N 
12 3481 Kavin 9500 9400 58 47 13 56 46 2 9 18 5 10 8.6 9.4 N N N N N N N N N N 
13 3496 Prakash 9200 9000 62 53 12 59 47 1 9 18 6 12 11.5 12.3 N N N N N N N N N N 




7800 7500 59 37 8 51 37 2 11 22 4 8 10.3 10.8 N N N N N N N N N N 
16 3574 Srinivasan 8900 8800 50 44 10 50 43 3 13 26 6 12 8.2 9.5 N N N N N N N N N N 
17 3575 Durga 9200 9100 68 47 12 64 46 1 16 32 7 14 9.5 10.8 N N N N N N N N N N 
18 3920 Govindamal 8700 8600 55 45 9 54 41 4 11 22 9 18 10.1 10.2 N N N N N N N N N N 
19 3921 Muthupandi 8800 8100 61 41 12 59 41 1 9 18 3 6 9.1 11.8 N N N N N N N N N N 
20 3953 Dharshneem 9200 9100 51 45 8 50 44 5 14 28 10 20 8.4 9.2 N N N N N N N N N N 
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PROGNOSIS 




















Before Treatment After Treatment 
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DISCUSSION 
 Atopic Dermatitis is a common pediatric problem seen in infancy and 
childhood.  Now a days allergic diseases are widely prevalent in people, this 
is because of changing in life style of the population, their dietic patterns,  
polluted atmosphere and seasonal changes. 
 In this study sixty cases were treated in the out patient and in patient 
department according to clinical features mentioned in siddha texts.  Siddha 
methods of diagnosis were carried out and recorded in selection proforma 
with the help of modern investigations.  The diagnosis were confirmed and 
treated with the drug “Nannari ver ennai” and clearly observed.  The 
observations are described under. 
 
1. Distribution according to sex 
 Among 50 cases 54% were males and 46% were female children. 
2. Distribution According to Age: 
 In 50 Patients 8% were 6 months – 1year, 32% were 1-3 years, 30% 
were 4-6 years, 30% of cases were 7-12 years.  
3. Religion among the patients 




4. Distribution according to socio-economic status. 
 Most of the patients 62% belonged to poor socio-economic status, 
36% were middle income groups and 2% were high income groups.  
 
5. Diet among the patients 
 Out of 50 Patients 96 % of cases were non- vegetarian, 4% were 
vegetarian. 
 
6.  Family history among the patients 
 Out of 50 patients, 62% of cases were positive family history, 38% 
were negative family history. 
 
7. Distribution according to paruva kaalam 
 According to paruva kaalam highest incidence of 56%  cases were 
noted in koothir kaalam.  In kaar kaalam 20%, Elavenil kaalam 10% 
Munpani kaalam 6%, Muduvenil kaalam 6%, Pinpani kaalam, 2% were 
noted. 
 
8. Mode of onset of symptoms of patients in Bala karappan. 
 Out of 50 cases, 94% of cases had chronic onset of symptoms, 6% of 
cases had acute onset symptoms. 
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9.  Distribution of Etiology 
 Out of 50 PatientsAero allergens sensitivity was seen in 14% of cases, 
positive family history was seen in 62% of cases, food allergen sensitivity 
was seen in 24% of cases. 
 
10. Vatham 
 Due to the derangement of different vatham Abaanan causes 
constipation in 56% of cases, Uthanan, Viyanan and samanan were deranged 
in 100% of cases, Devathathan was deranged in 60% of cases. 
 
11. Pitham 
 According to pitham derangement of prasagam causes thimir, thinavu, 
sori, pun, thadipu in 100% of cases, derangement of anal pitham was seen in 
40% of cases. 
 
12. Kabam 
 According to Iyyam, Kilethagam was affected in 67% of cases. 
 
13.Distribution according to ezhu udakattugal 
 In Ezhu udal kattukal saaram, senneer and kozhuppu were affected 




 In naadi vatha pitham was observed in 54% of cases, vatha kabam was 
observed in 10% of cases, pitha vatham was observed in 36% of cases, 
derangement of niram and sparisam observed in 100% of cases, Malam 
erugal was observed in 56% of cases. 
 
15.Neerkuri 
 Vaikkol niram was observed in 100% of cases. 
 
16.Neikuri 
 In this study most of patients had vatha neer neikuri.  In Bala karappan 
vatham is deranged followed by pitham and kabam. 
17. Distribution according to clinical presentation 
  Among 50 cases  100 % of the patients had Itching,  30%  had 
erythema, 100% of patients were had papules,  oedema seen in 6% of cases, 
vesicles, Oozing, excoriation and crusting were seen in  90% of cases, 4% 
were had  pustules, 20% of patients had scaling, 34% of patients had 
Xerosis, 50% of patients had Lichenification, 56% of patient had 
constipation. 
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18. Laboratory investigations 
 Most of the patients with AD had peripheral blood eosinophilia and 
increased serum IgE level, Increased ESR level and positive RASTs test. 
19. Antimicrobial activity 
 Antimicrobial activities of the Nannari ver ennai significantly 
inhibited the growth of bacterial strains against staphylococcus aureus and 
streptococcus pneumoniae. 
20. Biochemical analysis 
 The Bio chemical analysis of trial medicine showed the presence of 
calcium, sulphate, starch, ferrous iron, Tannic acid, unsaturated compound 
and amino acid. Topical sulphur is most commonly used to treat skin related 
conditions. 
21. Pharmacological analysis 
 The trial dry has significant Anti histamine, Anti inflammatory              
Anti pyretic and Analgesic activity. 
21. Treatment 
 The trial medicine for the treatment of Bala karappan was “Nannari 
ver ennai” both internally and externally. 




1-7 years 2.5ml, 2 times/day, after diet 
8-12 years 5ml, 2times/day, after diet 
 
 
External  - As needed 
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 The internal medicine was given for 7-15 days depending upon the 
severity of the disease and the condition of the patients within these days, 
most of the symptoms were releived and all the patients were advised to free 
from causative factors and to follow proper pathiyam. 
 
 The patients were advised to come as out patient for further follow up.  
They were followed up for a period of 35-45 days.  None of the patients 
complained of reccurence of the symptoms.  During and after the course of 
treatment no untoward effects were reported. 
 
Result: 
 The drugs chosen for trial medicine for the treatment of Bala karappan 
had specific pharmacologic actions Anti inflammatory, anti allergic, 
Analgesic, Anti fungal, Anti bacterial, Tonic, Astringent, Anti microbial, 
laxative, Anthelmintic, Antidote and Astringent. 
 
 Out of 50 Patients72% of cases showed significant improvement.  





  Fifty children with Bala karappan were diagnosed clinically for the 
trial as Out patient and Inpatient department for clinical dianosis, laboratory 
diagnosis and treatment of trial medicine. 
 The medicine chosen for clinical treatment and management of Bala 
Karappan was “Nannari ver ennai” both internal and external medicine. 
Internal 
Age Dosage 
1-7 years 2.5 ml, 2 times/day -after diet 
8-12 years 5 ml, 2 times/day -after diet 
 
External: As needed 
 They were treated for 7 to 15 days depending upon the severity of the 
illness with further follow up for any recurrence.    
The etiology and clinical features of Balakarappan may be correlated 
with Atopic Dermatitis. 
Clinical features of Bala karappan was done on the basis of clinical 
features described in Balavagadam text. 
More number of cases were admitted in koothir kalaam. 
Various siddha aspects and modern aspects of examination of 
Balakarappan were carried out and recorded in proforma. 
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Quetionnaires and case  sheets, lab investigation reports were 
maintained separately for each patients. 
Laboratory diagnosis was done by modern methods of examinations. 
 Out of the fifty cases, the signs and symptoms were releived in 72% of 
cases, Moderate improvement seen in 24% of cases, Mild improvement 
occurred in 4% of cases. 
 The observation made during the clinical study showed that the trial 
drug Nannari ver ennai was clinically effective. 
During and after the course of treatment no relapsing effects were 
reported.  Patients and their parents were educated about the do’s and don’ts 
during the course of treatment. 




 All the fifty patients of BALAKARAPPAN  treated with NANNARI 
VER ENNAI exerted good prognosis. 
 Clinical cases found to have significant improvement in 72% of cases, 
moderate improvement was found in 24% and mild improvement was found 
in 4% of cases. 
 No adverse effects were noticed during the treatment period.  The 
ingredients of Nannari ver ennai are plant origin mainly roots that are rich in 
phyto chemicals, easily available and harmless to children. 
Since my trial drug is a single medicine which can be used both 
internally and externally and its also cost effective. 
Hence, the medicine Nannari Ver ennai can be proved as an effective 





PREPARATION OF THE TRIAL MEDICINE 
 
ed;dhhp Nth; vz;nza;; ; ; ;; ; ; ;; ; ; ; 
ed;dhhp Nth; neUQ;rpy;Nth; rq;fk;Nth;ej;; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ; 
   ijr;#hpa;;; pd;Nth; RuNtUs;sp; ; ;; ; ;; ; ;  
td;rpw;wh tpiuapd;Nth; trk;gpt;NtO; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
   tifrkQ;Nrh;j; jiuj;njz;nza; jdpNa fha;r;rp; ; ; ; ; ; ; ;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ;  
ad;ghf tbj;Jz;zp fug;gNdF; ; ; ;; ; ; ;; ; ; ;  
   kjidNkw; G+rey khFKz;ik; ;; ;; ;  
nghd;khJ jpyfnkDQ; rugG+gd;; ; ;; ; ;; ; ; 
G+jyj;NjhHf; fpk;Kiwiag; Gfd;wthNw.; ; ; ; ;; ; ; ; ;; ; ; ; ;  
    
Mjhu E}y;:  ;;; ruNge;jpuh; itj;jpa Kiwfs; tpuz fug;ghd;  Nuhf  
  rpfpr;ir g.vz;: 248    
    
NrUk; ruf;FfSk; msTk; ; ;; ; ;; ; ; ;    
 ed;dhhp Nth;  (Hemidesmus indicus)   - 4.2 fpuhk; 
neUQ;rpy; Nth;  (Tribulus terrestris)  - 4.2 fpuhk; 
 rq;fk; Nth;  (Azima tetracantha)  - 4.2 fpuhk; 
 ej;ijr;#hp Nth; (Spermacoce hispida)  - 4.2 fpuhk; 
 <r;Ru%yp Nth; (Aristalochia indica)  - 4.2 fpuhk; 
 <Us;sp  (Allium Sativum)   - 4.2 fpuhk; 
 MthiuNth; (Cassia auriculata)   - 4.2 fpuhk; 
 trk;G  (Acorus Calamus)   - 4.2 fpuhk; 
 Mkzf;nfz;nza; (Castor oil)   - 280 kp.yp 
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ruf;Ffspd; Rj;jp Kiw:; ; ;; ; ;; ; ;  
 Nth;fis kz;> J}rp ePf;fp J}a;ikahf;fp vLj;Jf; nfhs;s 
Ntz;Lk;. 
 trk;gpid Rl;L fhpahf;fp vLj;Jf; nfhs;s Ntz;Lk;. 
 nts;isg;G+z;bid Nky; Njhy; ePf;fp vLj;Jf; nfhs;sNtz;Lk;. 
nra;Kiw:;;;  
 Nth;fis jdpj;jdpahf ed;F ,bj;J rypj;J t];jpufhak; 
nra;J #uzkhf;fp vLj;Jf; nfhs;s Ntz;Lk;. 
 G+z;bid fy;tj;jpypl;L miuj;J mjDld; trk;G Rl;l 
fhpapidAk;> #uzj;ijAk; Nrh;j;J NjitahdmsT ePHtpl;L miuj;J 
fw;fkhf;fp vLj;Jf; nfhs;s Ntz;Lk;. 
 fw;fj;jpid Mkzf;nfz;izAld; ed;F fye;J fha;r;rp jf;f 
gjj;jpy; tbj;J vLj;Jf; nfhs;s Ntz;Lk;. 
 




cl;gpuNahfk;; ;; ;; ; 
taJ msT fhyk;;;; 
1-7 taJ 2.5 kp.yp 2 Ntis 
8-12 taJ 5 kp.yp 2 Ntis 
 
czTf;Fg;gpd; 
ntspg;gpuNahfk; ; ;; ;; ; - Njitahd msT 
MAl;fhyk;; ;; ;; ; 





ed;dhhp (;;; Hemidesmus indicus) ed;dhhp Nth; (; ;; ;; ; Hemidesmus indicus) 
neUQ;rpy; (; ;; ;; ; Tribulus terrestris) neUQ;rpy; Nth; (; ; ;; ; ;; ; ; Tribulus terrestris) 
rq;fk; ; ;; ;; ; (Azima tetracantha) rq;fk; Nth; ; ; ;; ; ;; ; ; (Azima tetracantha) 
 
INGREDIENTS OF NANNARI VER ENNAI 
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INGREDIENTS OF NANNARI VER ENNAI 
ej;ijr;#hp  ; ;; ;; ; (Spermacoce hispida) ej;ijr;#hp Nth;; ; ;; ; ;; ; ; (Spermacoce hispida) 
 
<r;Ru%yp ;;; (Aristalochia indica) <r;Ru%yp Nth;; ;; ;; ; (Aristalochia indica) 
 
<Us;sp (;;; Allium Sativum) <Us;sp (;;; Allium Sativum) 
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Mthiu (Cassia auriculata) MthiuNth;;;; (Cassia auriculata) 
 
trk;G;;;  (Acorus Calamus) trk;G;;;  (Acorus Calamus) 
 
Vasambu Sutta Kari 
 




















































Mkzf;F ;;; (Ricinus communis) Mkzf;nfz;nza; ; ; ;; ; ;; ; ;  (Castor Oil) 
 
ed;dhhp Nth; vz;nza;; ; ; ;; ; ; ;; ; ; ; 
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PROPERTIES OF TRIAL DRUGS 
ed;dhhp Nth;; ;; ;; ; 
Botanical Name :  Hemidesmus indicus 
Family  :  Apocynaceae. 
NtWngah;;;;  :  mq;fhhp %yp> eWnel;b> ghjhs %sp> NfhghF>  
   rhhpgk;> ghw;nfhb> ePWz;b> fhdDrhhp>    
   fpU\;zty;yp> rhhpak;.  
 
tshpay;G;;;   : nfhb 
gad;gLk; cWg;G; ; ;; ; ;; ; ;  : Nth; 
Rit   : ,dpg;G> rpWifg;G 
jd;ik;;;   : jl;gk; 
gphpT   : ,dpg;G 
 
Chemical constituents 
 Coumarins, saponin, pregnane glycoside, sterols, Volatile oil,             
P-methoxy salicylic aldehyde. 
 
Pharmacological actions 
 Anti inflammatory, Anti allergic, Alterative, tonic, demulcent, 
sudorific, diaphoretic, diuretic. 
- Natkarni’s Indian Materia Medica, Volume – I, P.No-618 
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nghJFzk;;;; 
  ryNjhlk; gpj;jkjp jhfk; coiy; ; ;; ; ;; ; ;  
  ryNkW rPjkpd;dhH jQ;# P ; ;P ; ;P ; ; - Lyfkjpw;;;; 
  nrhd;dkJ Nkfk; Gz; RukpitNa yhnkhopf;Fk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
  nkd;kJu ed;dhhp Nth;; ; ;; ; ;; ; ;  
         - Njiuah; Fzthflk;; ;; ;; ; 
 
neUQ;rpy; Nth;; ; ;; ; ;; ; ; 
Botanical Name :  Tribulus terrestris 
Family  :  Zygophylaceae 
NtWngah;;;;  :  jphpfz;lk;> jphpfz;lfk;> jphpjz;lk;>  
neUQ;rpGJk;> mRtrl;buk;> Rtjl;lk;>  
Nfhfz;lk;> fhkurp> RthJfz;lk;> fpl;buk;>  
Nfhz;lk;> Rjk;. 
 
tshpay;G;;;   : jiuapy; glUk; Kl;nrb 
gad;gLk; cWg;G; ; ;; ; ;; ; ;  : r%yk; 
Rit   : Jth;g;G> ,dpg;G 
jd;ik;;;   : rPjk; 
gphpT   : ,dpg;G. 
Chemical constituents 
 Saponins, Campesterol,  β- sitosterol, stigmasterol, chlorogenin, 
diosgenin, rutin, rhamnose, astragalin, dioscin, diosgenin, hecogenin, 




 Astringent, Tonic, Demulcent, Analgesic, Antifungal, Anti bacterial, 
Aperient, cooling, diuretic, stomachic. 
    -Natkarni’s Indian Materia Medica. P.No-1230  
nghJf;Fzk;; ;; ;; ; 
  Nkfntl;il ePHr;RWf;F tPWjphp Njhlk;Gz;; P ; ; P ; ;; P ; ; P ; ;; P ; ; P ; ; 
  NtfhRu jhfntg;gk; tpl;nlhopAk; ; ; ; ;; ; ; ;; ; ; ; - Nghfe;;;; 
  jUQ;rpd kjiynkhopj; ijaNy; ;; ;; ; ! ey;y;;;  
  neUQ;rp yjid epid;;; . 
- mfj;jpah; Fzthflk;.; ; ;; ; ;; ; ;  
 
rq;fk; Nth;; ; ;; ; ;; ; ; 
Botanical Name :  Azima tetrachantha 
Family  :  Salvadoraceae. 
NtWngah;;;;  :  rq;fQ;nrb> ew;rq;fd;> Kl;rq;fd; 
tshpay;G;;;   : Kl;nrb 
gad;gLk; cWg;G; ; ;; ; ;; ; ;  : ,iy> Nth;> ghy; 
Rit   : ifg;G 
jd;ik;;;   : ntg;gk; 
gphpT   : fhHg;G 
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Chemical constituents 
 Azimine, azcarpine,carpaine, Fridelin, Lupeol, Glutinol,  β-sitosterol, 
flavonoids, terpenoids, tylophorine. 
Pharmacological actions 
 Astringent, Tonic, Anti arthritic, Anti periodic, Stimulant, diuretic. 
-Wealth of India Vol I (1985)  P.No-512 
nghJf;Fzk;:; ;; ;; ;  
  tPf;fk; P ; ;P ; ;P ; ; fug;ghd;;; ; tpjhfk; fpue;jpFd;kk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
  Cf;fkpF #iytha; NthLgpj;je; ; ; ; ;; ; ; ;; ; ; ; - jhf;Ftplk;; ;; ;; ; 
  tPWNkh fz;Jyq;Fk; tPRgjp uj;jKz;lhk;P ; ; ; P ; ; ;P ; ; ; P ; ; ;P ; ; ; P ; ; ; 
  $Wrq;fk; Nthpiy fl;F; ; ;; ; ;; ; ;  
- mfj;jpah; Fzthflk;.; ; ;; ; ;; ; ;  
ej;ijr;#hp; ;; ;; ;  
Botanical Name :  Spermacoce hispida 
Family  :  Rutaceae 
NtWngah;;;; :  fLfk;> Fopkpl;lhd;> #hp> ej;ijr;Rz;b>  
jhUzp> njhypahfuk;ig. 
tshpay;G;;;   : G+z;L tif 
gad;gLk; cWg;G; ; ;; ; ;; ; ;  : tpij> NtH 
Rit   : ,dpg;G> Jth;g;G 
jd;ik;;;   : jl;gk; 
gphpT   : ,dpg;G 
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Chemical Constituents 
 Borreline, ursolic acid, beta sitosterol, iso-rhamnetin 
Pharmacological actions 
 Alterative, Anti inflammatory, Anti bacterial, Anti occidant, Tonic, 
demulcent. 
    - Natkarni’s Indian material medica P.No-1162 
nghJf;Fzk;; ;; ;; ; 
  Rj;jKW khej;ijr; #hpnaDk; G+z;ljdhy;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
  nkj;jey NkAz;lhk; Nkjpdpapy; ; ; ; ;; ; ; ;; ; ; ; - tpj;jpw;Nfh; ;; ;; ;  
  ntg;gKW Ngjp ntz;rPjf; fl;Lg;; ; P ; ; ;; ; P ; ; ;; ; P ; ; ;Nghk;;;; 
  Jg;gwpe;j khNjeP nrhy;; ; P ;; ; P ;; ; P ; 
- gjhHj;j Fz tpsf;fk; ; ; ;; ; ;; ; ; - %y th;f;fk; ; ; ;; ; ;; ; ; P.No: 439 
 
<r;Ru%yp Nth;; ;; ;; ; 
Botanical Name :  Aristalochia  indica 
Family  :  Aristalochiaceae 
NtWngah;;;;  : <Ru%yp> ngUkUe;J> ngUq;fpoq;F>  
jiyr;RUsp> juhRf;nfhb    
tshpay;G;;;   : nfhb 
gad;;;;gLk; cWg;G; ;; ;; ;  : ,iy> Nth; 
Rit   : ifg;G 
jd;ik;;;   : ntg;gk; 
gphpT   : fhHg;G 
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Chemical Constituents 
 Aristalochic acid, Aristolactone, Aristolochene, Ishwarol, 
sequiterpene, Nitro phenanthrene derivatives. 
 
Pharmacological actions 
 Stimulant, Tonic, Antidote, Alexiteric, Anti arthritic, Febrifuge, 
emmenagogue, carminative. 
    - Natkarni’s Indian material medica P.No-139 
nghJf;Fzk;:; ;; ;; ;  
  jphpNjhlk; ntg;G rpuq;Fnrhwp eQ;Nrh; ; ; ;; ; ; ;; ; ; ;  
  lhpNjky; td;GilA kz;lh ; ; ;; ; ;; ; ; – njhUthd;;;; 
  mUkUe;ij nahj;j tzq;Nf; ; ;; ; ;; ; ; ! Ayfpw;;;; 
  ngUkUe;i;;; j ePnaLj;j gpd;G.P ; ;P ; ;P ; ;  
   - gjhHj;j Fz tpsf;fk; ; ; ;; ; ;; ; ; - %y th;f;fk; ; ; ;; ; ;; ; ; P.No: 99 
<Us;sp;;;  
Botanical Name :  Allium sativum 
Family  :  Liliaceae 
NtWngah;;;;  : ,yRdk;> fhak;> cs;sp> G+z;L>  
nts;isg;G+z;L> nts;ntq;fhak;.  
tshpay;G;;;   : G+z;L tif 
gad;gLk; cWg;G; ; ;; ; ;; ; ;  : fpoq;F 
Rit   : fhHg;G 
jd;ik;;;   : ntg;gk; 




 Allicin, phytoncidea, scordine A1 A2 & B flavonoids, vitamin B and 
minerals, anthocyanin, cyanidin-3-glucoside, Amino acids leucine, 
Methionine, s-propyl-L-cysteine, s-allyl cysteine, s-allyl cysteine sulphodixe. 
 
Pharmacological actions 
 Anti fungal, anti microbial, anti bacteial, anti inflammatory, 
anthelmintic, anti septic, anti spasmodic, alterative, carminative, stimulant, 
diaphoretic, expectorant, diuretic, tonic, emmenogogue. 
    - Wealth of India Volume I – P.No: 184  
nghJf;Fzk;; ;; ;; ; 
  ghyfw;F Kw;w ghpthFk; Nghlfj;ij; ; ; ;; ; ; ;; ; ; ;  
  Nkyfj;Jq; fhkhiy tPf;fk; Nghk; ; ; P ; ; ;; ; P ; ; ;; ; P ; ; ; - rPyKld;P ;P ;P ; 
  thUs;spf;Fk; td;KiyaPH; ; ; ; P; ; ; ; P; ; ; ; P ! G+jyj;jpy;; ;; ;; ; 
  ePUs;spr; nra;Ak; epjk;.P ; ; ; ; ;P ; ; ; ; ;P ; ; ; ; ;  
      -mfj;jpah; 2000 ; ;; ;; ; III-k; ghfk;; ;; ;; ;  
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Mthiu 
Botanical Name :  Cassia auriculata 
Family  :  Caesalpinaceae 
NtWngah;;;;  :  Mtiu> Mtpiu> VkGl;gp> Nkfhhp> MFyp>  
jyNghlk;. 
tshpay;G;;;   : Fj;Jr;nrb 
gad;gLk; cWg;G; ; ;; ; ;; ; ;  : ,iy> G+> gl;il> tpij 
Rit   : Jth;g;G 
jd;ik;;;   : jl;gk; 
gphpT   : ,dpg;G 
Chemical Constituents 
 Flavonoids. polysaccharides, tannins, saponins, ash 
 
Pharmacological actions 
 Astringent, Tonic, Alterative, Anti microbial, Anti inflammatory, 
attenuant, refrigerant.                          - Wealth of india – P.No: 97 
nghJf;Fzk;:; ;; ;; ;  
 Nkfj;jpdhNy tpise;jryk; ntl;ilady;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
 Mfj;j;;; pd; Gz;Nzh lUq;fpuhzp ; ; ;; ; ;; ; ; – Nghfe;jhd;; ;; ;; ; 
 Mthiug; gQ;rfq;nfhs; mj;jpRuk; jhfKk;Nghk;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; 
 Vthiuf; fz;klkh Nj; ;; ;; ; ! 
      - mfj;jpah; Fzthflk;; ; ;; ; ;; ; ; 
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trk;G;;;  
Botanical Name :  Acorus calamus 
Family  :  Arecaceae   
NtWngah;;;;  :  cf;fpuk;> trk;> tir> Ntzp> RLthd;>  
ciug;ghd;> Ngh; nrhy;yh kUe;J> gps;is  
kUe;J 
tshpay;G;;;   : G+z;L tif 
gad;gLk; cWg;G; ; ;; ; ;; ; ;  : kl;lepyj;jz;L  
Rit   : fhHg;G 
jd;ik;;;   : ntg;gk; 
gphpT   : fhHg;G 
Chemical Constituents 
 α asarone and β asarone, choline, acoric acid, tannins, calcium 
onalate, chlorpromazine, sesquitepenoids, eugenol, monoterpenas. 
Pharmacological actions 
 Sedative, Analgesic, Anti bacterial, anti spasmodic, carminative, 
anthelmintic, stimulant, tonic, antidote, anti fungal, anti cholinergic, 
astringent. 
     - Wealth of india – P.No: 63. Volume I. 
nghJf;Fzk;; ;; ;; ; 
  ghk;ghjp eQ;rw; Gjg;Gz; typtplghfq;Fd;kk;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; 
  #k;gh hpuj;jgpj; jk;Kf ehw;wk;td; #iy rd;dp; ; ; ; ; ; ; ;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ;  
  tPk;ghk;ig fhrk; gpyPfQ; rpypgjk; tPwpUky;P ; ; ; P ; ; P ;P ; ; ; P ; ; P ;P ; ; ; P ; ; P ; 
jhk;ghq; fpUkp apitNaO khrpt rk;gpidNa.; ; ;; ; ;; ; ;  
       - Njiuah; Fzthflk; 
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Castor oil 
Botanical Name :  Ricinus communis 
Family  :  Euphorbiaceae 
NtWngah;;;;  : Vuz;lk;> rpj;jpuk;> jy&gk;    
tshpay;G;;;   : Fj;Jr;nrb 
gad;gLk; cWg;G; ; ;; ; ;; ; ;  : ,iy> Nth;> tpj;J 
Rit   : ,dpg;G 
jd;ik;;;   : jl;gk; 
gphpT   : ,dpg;G 
Chemical Constituents 
 Linoleic acid, oleic acid, dihydrostearic acid, ricinoleic acid, palmitin. 
 
Pharmacological actions 
 Laxative, Emollient, Anti rheumatic. 
    - Natkarni’s Indian Materia Medica P.No:1065 
nghJf;Fzk;; ;; ;; ; 
 Mkzf;F;;;  nea;ahy; eyKz;lhk; ahth;f;Fk;; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; 
 G+kzf;F Nkdp GhpFoNy ;;; – tha;kzf;ff;; ; ;; ; ;; ; ; 
 nfhs;spy; tapWtpLq; NfhuKs;s thAtWk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
 cs;spy;tU Fd;kk;Ngh NkhJ; ; ; ;; ; ; ;; ; ; ; . 
- mfj;jpah; Fzthflk;.; ; ;; ; ;; ; ;  
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ed;dhhpNth; vz;nza; Kf;Fw;wj;ij; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ;  jd;dpiyg;gLj;Jk; ; ; ; ;; ; ; ;; ; ; ; tpjKk;;;; 
 Neha; ePf;f KiwAk;; P ; ;; P ; ;; P ; ; 
t.vz;;;; NrUk; kUe;Jfs;; ; ;; ; ;; ; ;  Rit jd;ik;;;  gphpT tPhpak;P ;P ;P ; Ik;G+jq;fs;; ; ;; ; ;; ; ; Kf;Fw;wq;fs;; ; ; ;; ; ; ;; ; ; ; 
1. ed;dhhp Nth;; ;; ;; ; ,dpg;G> 
rpWifg;G 
jl;gk; ,dpg;G rPjk; kz; + ePH Iak; 
2. neUQ;rpy; Nth;; ; ;; ; ;; ; ; Jth;g;G> ,dpg;G rPjk; ,dpg;G rPjk; kz; + 
fhw;W 
Iak; + tsp 
3. rq;fk; Nth;; ; ;; ; ;; ; ; ifg;G ntg;gk; fhHg;G rPjk; fhw;W + 
tpz; 
tsp 
4. ej;ijr;#hp Nth;; ; ;; ; ;; ; ; ,dpg;G> Jth;g;G jl;gk; ,dpg;G rPjk; kz; + ePH Iak; 
5. <r;Ru%yp Nth;; ;; ;; ; ifg;G ntg;gk; fhHg;G rPjk; fhw;W + 
tpz; 
tsp 
6. <Us;sp;;;  fhHg;G ntg;gk; fhHg;G c\;zk; fhw;W + jP tsp + jP 
7. Mthiu Nth;;;; Jth;g;G jl;gk; ,dpg;G rPjk; kz; + 
fhw;W 
Iak; + tsp 
8. trk;G;;;  fhHg;G ntg;gk; fhHg;G c\;zk; fhw;W + jP tsp + jP 





ed;dhhpNth; vz;nza; Kf;Fw;wj;ij jd;dpiyg;gLj;Jk; tpjKk;; ; ; ; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ; ; ; ; 
 Neha; ePf;f KiwAk;; P ; ;; P ; ;; P ; ; 
tsp thOkplk;;;; 
  cz;b rikj;Jlw; $l;Lq; Flw;gFjp; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
   jpz;bw nyd;G nrtpFwq;F ; ; ;; ; ;; ; ; – tpz;l;;;  
  njhLTzh;T Njhw;Wtpf;Fk; NjhypLg;gpt; thWk;; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; 
   tLtp yplkhk; tspf;F; ;; ;; ;  
 
czitr; rPuzpf;fr;nra;J clYf;F Vw;f itf;Fk; ,lkhfpa 
gf;Fthrak;> vd;G> fhJ> njhil> Njhy;> ,Lg;G Mfpa MWk; 
Fw;wkw;w thAtpd; ,lkhk;.  fug;ghd; gpzpapy; Kjd;ikahf 




  ghug;gh G+jike;J kz;ePH NjA; ; ; P; ; ; P; ; ; P  
   ghpthA thfha ike;jp dhNy;;;  
  Nrug;gh rlkhr;R kz;zpd; $W; ; ; ;; ; ; ;; ; ; ;  
   nrwpkaph;Njhy; vd;gpiwr;rp euk;ige; jhFk;....; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ;  
 
Njhy; kz;zpd; $Wghbid cilajhifahy;> ed;dhhp Nth; 
vz;nza;apy; Ik;G+jq;fspy; kz;G+jf; $WghL mjpfk; cs;sjhy; mJ 




 ed;dhhp Nth; vz;nza;apid ntspg;gpuNahfkhf 
gad;gLj;j mjpy; cs;s Mkzf;F vz;nza;ahdJ thjj;jpd; 
Fzkhd twl;rpia ePf;Ffpd;wJ.  NkYk; ,jpy; cs;s Mkzf;F 
vz;nza;apd; FzkhdJ cl;gpuNahfkhf gad;gLj;Jk; nghJ 
thjj;jpdhy; ghjpf;fg;gl;l kyf;fl;bid rPHnra;fpd;wJ. 
ed;dhhp Nth; vz;nzahdJ gpj;j Fw;wj;jp; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; id jd;dpiyg;gLj;Jk;Kiw; ; ; ;; ; ; ;; ; ; ;  
 ke;jphpg; gz;Gld; .......; ; ; ;; ; ; ;; ; ; ;  
 ke;jKk; jd;ikA kpize;jpbNyh; ; ; ;; ; ; ;; ; ; ;  
 kw;nwhU Nehapy;iy kdpjUf;Nf; ; ;; ; ;; ; ;  
 fgj;jpd; Fzkhd rPjsKk; ke;jKk;> gpj;j Fw;wj;jpid rPH 
nra;fpd;wd. 
ed;dhhp Nth; vz;nzapdhy; thjk; jd;dpiyailAk; tpjk;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; 
 
  thAtpd; Fzj;Jld; #lDfpy;; ; ; ;; ; ; ;; ; ; ; 
   thAtp dplq;fspy; Neha;fSz;L; ; ; ;; ; ; ;; ; ; ;  
  thAtpy; Fsph;r;rpjhd; $bbNyh; ; ; ;; ; ; ;; ; ; ;  
   te;jpLk; eypfSk; Ntwplj;Nj; ; ; ;; ; ; ;; ; ; ;  
  thAtpy; mdy;jUk; nea;g;gike;jhy;; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; 
   thATk; mlq;fpLk; tha;ikapJ; ; ; ;; ; ; ;; ; ; ;  
  thAtpd; gpzpfisg; Nghf;fplNt; ; ;; ; ;; ; ;  
   tFj;jpLk; Kdpnkhop fz;bLNk.; ; ;; ; ;; ; ;  




 ntg;gKs;s nea;g;girahdJ thAtpd; Fzj;Jld; Nrh;e;jhy; 
thj Fw;wkhdJ jd;dpiyailAk;. 
 vdNt fug;ghd; gpzpapy; Kjd;ikahf ghjpf;fg;gl;l thjf; 
Fw;wj;jpid ed;dhhp Nth; vz;nza;apy; cs;s gpj;jj;jpd; Fzkhd 
ntg;gKk;> fgj;jpd; Fzkhd nea;g;Gj; jd;ikAk; thjf; Fw;wj;jpid 
jd;dpiyailar; nra;fpd;wd. 
 
ed;dhhp Nth; vz;nzapdhy; Iak; jd;dpiyailAk; tpjk;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; 
 
  Nrj;Jkf; Fzj;Jld; nea;g;girAk;; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; 
  rPjKQ; Nrhpyh iktapNdha;P ; ;P ; ;P ; ; 
  Nrj;Jkf; Fzj;Jld; NrudYf;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
  Nfw;gLk; Neha;fSkl; Ntwplj;Nj; ; ; ; ;; ; ; ; ;; ; ; ; ;  
  jPHj;jpL twl;rpAk; jPf;FzKk;P ; ; ; P ; ;P ; ; ; P ; ;P ; ; ; P ; ; 
  jPHe;jpLQ; Nrh;j;Jkj; jPg;gpzpnad;P ; ; ; ; ; P ; ;P ; ; ; ; ; P ; ;P ; ; ; ; ; P ; ; 
  Nwj;jpL jfTilNahd; ngWNk; ;; ;; ;  
  ,j;jiur; rpj;jhpd; Ma;TiuNa.; ; ; ; ;; ; ; ; ;; ; ; ; ;  
      - rpj;j kUj;Jthq;f RUf;fk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
 
 tpfhuKw;w Nrj;Jk Fw;wj;jpid> twl;rpAk; ntg;gKk; 
jd;dpiyailar; nra;fpd;wd. 
 ed;dhhp Nth; vz;nza;apy; cs;s thjj;jpd; Fzkhd twl;rpAk;> 
gpj;jj;jpd; Fzkhd ntg;gKk; fgf; Fw;wj;jpid jd;dpiyailar; 
nra;fpd;wd. 
 
ed;dhhp Nth; vz;nza;apd;; ; ; ; ;; ; ; ; ;; ; ; ; ; Ritfisf; nfhz;L fgk; ; ; ;; ; ;; ; ;
jd;dpiyailjy;; ;; ;; ; 
 ed;dhhp Nth; vz;nza;apy; cs;s fhHg;G> Jth;g;G> ifg;G> 
Ritfs; fgf;Fw;wj;jpid jd;dpiyg;gLj;Jfpd;wd. 
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BIO-CHEMICAL ANALYSIS OF NANNARI VER ENNAI  
Preparation of the extract:   
  5gms of the drug (powder without oil ) was weighed accurately and 
placed in a 250ml clean beaker.  Then 50ml of distilled water is added and 
dissolved well.  Then it is boiled well for about 10 minutes.  It is cooled and 
filtered in a 100ml volumetric flask and then it is make up to 100ml with 
distilled water.  This fluid is taken for analysis. 
 
QUALITATIVE ANALYSIS 
S.NO EXPERIMENT OBSERVATION INFERENCE 
1.  TEST FOR CALCIUM 
2ml of the above prepared extract is 
taken in a clean test tube. To this 








2. TEST FOR SULPHATE 
2ml of the extract is added to 5% 







3.  TEST FOR CHLORIDE 







4. TEST FOR CARBONATE 








5. TEST FOR STARCH 
The extract is added with weak 
iodine solution 






6.  TEST FOR FERRIC IRON 
The extract is acidified with Glacial 
acetic acid and potassium ferro 
cyanide. 




7. TEST OF FERROUS IRON  
The extract is treated with 
concentrated Nitric acid and 
Ammonium thio cyanate solution 





8.  TEST FOR PHOSPHATE 
The extract is treated with 
Ammonium Molybdate and 






9.  TEST FOR ALBUMIN 







10.  TEST FOR TANNIC ACID 








11.  TEST FOR UNSATURATION 
Potassium permanganate solution is 








12.  TEST FOR THE REDUCING 
SUGAR 
5ml of Benedict’s qualitative 
solution is taken in a test tube and 
allowed to boil for 2 mts and add 8-
10 drops of the extract and again 
boil it for 2 mts. 






13.  TEST FOR AMINO ACID 
One or two drops of the extract is 
placed on a filter paper and dried 
well. After drying, 1% Ninnhydrin 
is sprayed over the same and dried 
it well. 





14. TEST FOR ZINC 









  The extract prepared from the given sample Nannari ver ennai 
contains calcium, sulphate, starch, ferrous iron, tannic acid, unsaturated 




ANTI – HISTAMINE EFFECT OF NANNARI VER ENNAI 
ON ISOLATED GUINEA PIG ILEUM 
Aim: 
 To find out the anti-histamine effect of Nannari Ver Ennai on isolated 
guinea pig ileum. 
 
Preparation of the test drug: 
 A dose of 2 ml was given to guinea pig. 
Solutions required: 
 Histamine – 1 in 1,00.000 strength, 
 Test drug- Nannari Ver Ennai (2ml) 
 
Nutrient solution: 
 Tyrode – 1 to 2 litres 
 
Tissue used: 
 Isolated guinea pig ileum 
 
Apparatus required: 
• Student’s organ bath 
• Sherrington rotating drum 
Procedure: 
 An overnight fasted guinea pig weighing about 400 gms was 
sacrificed by a blow on the head and by cartoid bleeding.  The abdomen was 
suddenly opened and ileo caecal junction was found out.  A small piece of 
ileal portion was cut and removed and placed in a dish, containing warm 
aerated tyrode solution. 
 The lumen of the ileum was gently rinsed out by pushing tyrode 
solution into it, 3 m length segment was cut from this part of ileum and was 
tied with thread on both ends without closing the lumen and the tissue was 
mounted in the organ bath containing tyrode solution maintained at 37°C and 












 First the drum was allowed to run for 1 minute from  the baseline.  
Drugs were given to study the inhibiting effect of histamine 0.2ml of 
histamine was added and allowed to run the drum for 30 seconds.  Thus the 
tissue was standardized and then the drum was stopped and the histamine 
was washed out. 
 
 Again the tyrode solution was added to the organ bath till the lever 
comes to the baseline.  The drum was allowed to run for 1 minute. 
 
 To the organ bath 1 ml of test drug was added, waited for 1 minute 
then 0.2ml of histamine was added and the drum was allowed to run for 30 
seconds.  The response was recorded. 
 
Inference : 
The drug Nannari Ver Ennai has got significant Anti  
histamine activity.
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ACUTE ANTI - INFLAMMATORY STUDY ON  
NANNARI VER ENNAI – BY HIND-PAW METHOD  
IN ALBINO RATS 
Aim: 
 To study the acute anti-inflammatory effect of Nannari Ver Ennai 
 
Preparation of the test drug: 
  A dose of 2 ml was given to each  rat. 
Procedure: 
 Six healthy albino rats weighing 100-150 gm were taken and divided 
into three groups, each consisting of 2 rats. 
 First group was kept as control by giving distilled water of 2 ml /100 
gm of body weight.  The second group was given Ibubrufen at dose of 
20mg/100 gm of body weight.  The third group received the test drug 2ml of 
Nannari Ver Ennai. 
 Before administration of test drug, the hind-paw volumes of all rats 
were measured.  This was done by dipping the hind-paw (up to tibio-tarsal 
function) in to a mercury plethysmography.  While dipping the hind-paw, by 
pulling the syringe piston, the level of mercury in the centre small tube was 
made to coincide with red marking and reading was noted from the 
plethysmograph. 
 Soon after the measurement, the drugs were administered orally.  One 
hour later, a subcutaneous injection of 0.1 ml of 1% (w/v) carrageenin in 
water was made into plantar surface of both hind-paw of each rat.  Three 
hours after carrageenin injection, the hind – paw  volumes were measured 
once again.  The differences between the initial and final volumes were 
calculated and compared. 
 The method is more suitable for studying the anti-inflammatory 
activity in acute inflammation.  The values are given in the table: 
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Control Water 2ml 1.55 1.4 0.85 100 - - 











  Nannari Ver Ennai has significant acute anti-inflammatory action.  
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ANTI-PYRETIC STUDY OF NANNARI VER ENNAI 
(By yeast induced method) 
Aim: 
 To study the anti pyretic activity of Nannari Ver Ennai 
 
Procedure: 
 Group of six albino rats were selected and divided equally into 3 
groups.  All the rats were made hyperthermic by subcutaneous injection of 
12% suspension of yeast at a dose of 1 ml/100 gm of body weight. 
 
 10 hours later one group of animals received only distilled water at a 
dose of 2ml. Second group received standard drug paracetamol 20 mg/ml 
and the third group received the test drug by gastric tube at a dose of  2ml.  
 Then mean rectal temperature for the 3 groups were recorded at                   
0 hour. 1 ½ hours, 3 hours and 4 ½ hours after the drug administration.  The 
different between the mean temperature of the control group and that of the 
other groups was measured. 
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TABULATION OF RESULTS OBTAINED 
 





































































  The drug Nannari Ver Ennai has significant antipyretic action. 
 114
ANALGESIC STUDY ON NANNARI VER ENNAI  BY TAILFLICK 
METHOD IN ALBINO RATS 
Aim: 
 To study the analgesic effect of Nannari ver ennai. 
 
Preparation of the test drug: 
 A dose of 2 ml was given to each rat.  
 
Instrument: 
 Analgesic meter (or) Dolori meter using heated michrome wire as the 
source of stimulus. 
 
Procedure: 
 Three groups of healthy albino rats on both sexes were selected, each group 
having 3 rats. Each rat was put inside a rat holder with the tail projecting out fully. 
The tip of the tail was kept over the michrome wire of the analgesic meter without 
touching it.  
 Now the current of 5 MA was passed through the analgesic meter to heat 
the microme wire by switching it on, at the sometime starting a stopwatch. The 
time taken for the rat to flick the tail was noted. This is the reaction time. The 
reaction time is noted for each rat and the average is calculated. 
 First group was given 2 ml of distilled water and kept as control. Second 
group was administered with paracetamol at a close of 20 mg / 100 gm of body 
weight orally. The test drug Nannari ver ennai was administered to the third group 
at a dose of 2 ml of body weight. 
 After the lapse of half an hour and one hour, the reaction time of each rat 
was noted in each group at an interval of 2 minutes (when a rat fails to flick the 
tail, it should not be continued beyond 8 seconds to avoid injury) and the average 
was calculated. 
 The results of control group, standard group and drug treated group were 
tabulated and compared. 
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EFFECT OF NANNARI VER ENNAI 
 
Inference: 




Name of the 
drugs / 
groups 










1 Water 2 ml 2.0 sec 2.0 2.0 - 
2 Paracetamol 20 mg           4.5 sec 6.5 6.5 Good 
3 Nannari ver 
ennai 






 To study the Anti-microbial action of “Nannari ver  ennai” done by 
“Paper disc agar diffusion method” – Kirby – bauyer method. 
Medium 
Muller Hinton agar. 
Components of medium 
Beef extract   - 300gms/lit 
Agar    - 17 gms/lit 
Starch   - 1.5 gms/lit 
Casein Hydrolysate - 17.5 gms/lit 
Distilled water  - 1000 ml 
PH    - 7.6 
Procedure 
Inoculum preparation 
 The given micro organism is inoculated in 1 ml of peptone water 
under sterile condition.  The inoculum is incubated at 37°C for 2 hours then 
the turbidity of the inoculum is adjusted to 0.5 µc Forland turbidity standard.  
The inoculum was poured in a Muller Hinton agar plate and uniformly 
spreaded over the plate.  The excess inoculum was discarded. 
Disc preparation 
 The known quantity of the given chemical compound is impregnated 
in a 6mm diameter filterpaper disc and applied over the inoculum.  Then the 
Muller Hinton agar plate is incubated at 37°C for over night.  The zone of 
clearance is measured with a scale and the sensitivity of the organism to the 
given trial drug is asscessed.  The diameter of zone of inhibition was 
observed and recorded. 
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GOVT SIDDHA MEDICAL COLLEGE AND HOSPITAL 
  PALAYAM KOTTAI  
DEPARTMENT OF KUZHANTHAI MARUTHUVAM  
SCREENING PROFORMA CASE SHEET 
Name  :__________________________________________________  
Address :__________________________________________________ 
_______________________________Tel.No_____________ 
Age  :_______________________________Sex: _______________ 
 
Fathers occupation: ____________________________________________ 
Presenting complaints: _________________________________________ 
Age at onset of symptom: _______________________________________ 
Duration : ____________________________________________________ 
Site of lesion : _________________________________________________ 
Numer of  similar episodes : ______________________________________ 
Itching  
 Duration : ______________________ 
 Predominantly            Day           Night   No diurnal variation 
Sleep disturbance     Yes  No  
Discharge      Yes           No 
Dryness      Yes          No 
Scaling      Yes          No 
Aggravating factors ____________________________________________ 
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Effect of 
 Dust    exacerbation   No effect 
 Cold wind   exacerbation   No effect  
Hot climate   exacerbation   No effect  
Sweating   exacerbation   No effect  
Dampness   exacerbation   No effect  
Vehicular smoke  exacerbation   No effect  
Cooking fuel smoke  exacerbation   No effect  
Cigarette / beedi smoke exacerbation   No effect  
Plants, grass, weeds exacerbation   No effect  
Harvesting or 
Wheat threshing  exacerbation   No effect  
Pet animals   exacerbation   No effect  
Detergents, soaps  exacerbation   No effect 
Clothing   exacerbation   No effect 
Psychological stress exacerbation   No effect 
Birch    exacerbation   No effect 
Ragweed   exacerbation   No effect 
Eating  
 
Egg/ Egg Products  exacerbation   No effect  
 
Cow’s milk   exacerbation   No effect  
 
Peanut   exacerbation   No effect  
 
Fish , Shell fish  exacerbation   No effect  
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Soya    exacerbation   No effect  
 
Walnut   exacerbation   No effect  
 
Banana   exacerbation   No effect  
 
Grains   exacerbation   No effect  
 
Apple    exacerbation   No effect 
 
Carrot   exacerbation   No effect 
 
Potato   exacerbation   No effect 
 
Cherry   exacerbation   No effect 
 
Watermelon   exacerbation   No effect 
 
Honey dew   exacerbation   No effect 
 
Seasonal variation: 
   Is there seasonal variation of symptoms  Yes   No  
 
Family History: 
   
  Number of family members :_____________________________ 
 
 Number of Siblings  : Older ________ Young__________ 
 
 Presence of overcrowding    Yes   No 
 Family History of similar complaints   Yes  No 
 Family History of  Asthma    Yes  No 
    Cough    Yes  No 
    Wheezing    Yes   No 
    Frequent Nose Block  Yes  No 
    Frequent Running nose  Yes  No 




 Presence of dampness     Yes  No 
 Use of carpets      Yes  No 
 Use of dusty curtains     Yes  No 
 Use of soft toys      Yes  No 
 Presence of pets /  household animals   Yes  No 
 Presence of cockroaches     Yes  No 
 Presence of dusty bookshelves    Yes  No 
Treatment History: 
History of  Previous hospitalizations   Yes  No 
No. of  previous hospitalizations   ____________ 




GOVT SIDDHA MEDICAL COLLEGE AND HOSPITAL 
  PALAYAM KOTTAI  
DEPARTMENT OF  KUZHANTHAI MARUTHUVAM  
PROFORMA OF CASE SHEET FOR BALA KARAPPAN 
IP. No  :     Nationality  : 
Name   :     Religion  : 
Age          :     Date of Admission : 
Sex        :     Date of Discharge : 
Address    :     Diagnosis  : 
Informant  :     Medical Officer : 
 
1. Complaints and duration  :    
2. History of present illness  :    
3. History of Past illness           :    
4. Antenatal history  :     
5. Birth history   :     
6. Neonatal history  :    
7. Developmental  history : 
8. Nutritional  history  : 
9. Immunization history            : 
10. Family history   : 
11. Socio economic status : 
General examination 
1.   Appearance and posture : 
2.   Nutritional status                  : 
3. Anaemia   : 
4. Cyanosis   : 
5. Clubbing  : 
6. Jaundice   : 
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7. Lymphadenopathy : 
8. Abdominal distension : 
9. Pedal oedema  : 
Vital Signs 
1. Temperature  : 
2. Pulse rate  : 
3. Respiratory rate : 
4. Heart rate  : 
          5.  Blood pressure    : 
Anthropometry    
          1. Height   : 
          2. Weight   : 
 
SIDDHA ASPECTS  
Nilam 
 
1. Kurinji   : 
2. Mullai   : 
3. Marutham  : 
4. Neithal   : 
5. Paalai    : 
Paruvakaalam 
1. Kaar   : 
2. Koothir   : 
3. Munpani    : 
4. Pinpani  : 
5. Elavenil  : 
6. Muthuvenil  : 
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Poripulangal   
1. Mei  : 
2. Vai  : 
3. Kan  : 
4. Mooku  : 
5. Sevi  : 
Kanmenthiriyangal  
1. Kai  :  
2. Kaal  : 
3. Vaai  : 
4. Eruvai  : 
5. Karuvai  : 
Uyir thathukkal  
Vadham 
1. Pranan  : 
2. Abaanan  : 
3. Viyanan  : 
4. Uthanan  : 
5. Samaanan : 
6. Naagan  : 
7. Koorman : 
8. Kirukaran : 
9. Devathathan : 
10. Dhananjeyan : 
Pitham 
1. Analpitham : 
2. Ranjagam : 
3. Saadhagam : 
4. Prasagam : 
5. Aalosagam : 
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Kabam 
1. Avalambagam  : 
2. Kilethagam   : 
3. Pothagam  : 
4. Tharpagam  : 
5. Santhigam  : 
Udar kattugal 
1. Saaram   : 
2. Senneer   : 
3. Oonn   : 
4. Kozhuppu  : 
5. Enbu   : 
6. Moolai   : 
7. Sukkilam / Suronitham:    
 
Envagai thervugal 
1. Naadi   : 
2. Sparisam   : 
3. Naa   : 
4. Niram            : 
5. Mozhi   :  
6. Vizhi            : 
7. Malam   : 
8. Moothiram   : 
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MODERN ASPECTS  
SKIN – Clinical Examination: 
  Inspection   : 
  Palpation   : 
  Site of the lesion  : 
  Shape of the lesion : 
  Size of the lesion  : 
  Colour of the lesion :  
  Itching   : 
  Erythema    :  
  Papules   : 
  Oedema   : 
  Vesicles   : 
  Oozing   : 
  Excoriation   : 
  Crusting   : 
  Pustules   :  
  Xerosis   : 
  Scaling   : 
  Lichenification  : 
 
Examination of other system 
Cardiovascular system  
Gastro intestinal system 





Laboratory investigations  
Blood 
TC    : 
DC    : 
ESR   : 
1
/2 hr,  : 
1 hr  : 
Hb%  : 
Urine 
  Albumin   : 
  Sugar   : 
Deposits  : 
Stools 
Ova   :  
Cyst   : 
Specific investigations 
 Skin prick test for IgE. 
 Specific IgE antibody test 
Radio allergen Sorbent assay
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Investigations - Siddha aspect 
       1. Neerkuri 
Niram : 
Edai  : 
     Manam :   
     Nurai  : 
Enjal  : 
2.Neikuri  : 
3.Daily progress : 
Date Symptoms Medicine 
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GOVT. SIDDHA MEDICAL COLLEGE AND HOSPITAL,  
POST GRADUATE DEPARTMENT. PALAYAMKOTTAI.  
DEPARTMENT KUZHANTHAI MARUTHUVAM 
ADMISSION - DISCHARGE SHEET 
Name of the Medical Unit: 
IP. NO   : 
Bed no   : 
Ward    : 
Name   : 
Age    : 
Sex   : 
Permanent address : 
Temporary address : 
Informant   : 
 
S.No 
CLINICAL FEATURES               





1 Itching   
2 Erythema   
3 Papules   
4 Oedema   
5 Vesicles   
6 Oozing   
7 Excoriation   
8 Crusting   
9 Pustules   
10 Scaling   
11 Xerosis   
12 Lichenification   
13 Constipation   
 
Occupation   : 
Income   : 
Nationality   : 
Religion  : 
Date of Admission : 
Date of discharge : 
Diagnosis   : 
Results  : 






2. Sarabendhirar vaidhya muraigal virana karappan roga sigichai. 
3.  Gunapadam Mooligai and Thaathu vaguppu 
4.  Padhaartha Guna Sindhamani 
5.  Siddha Maruthuvam – Sirappu 
6.  Siddha Maruthuvanga Surukkam Dr.Uthamarayan. 
7.  T.V.Samba Sivam Pillai – Tamil English Dictionary 
8.  Madhalai Noi Nool – Thogudhi I 
9.  Pillai Pini Maruthuvam Volume I & II 
10. Athmaratchamirtham ennum vaidhya saara sangiragam 
11. Sathaga naadi 
12. Roga nirnaya saaram 
13. Pararasasegaram 
14. Agasthiar vaidhya kaviyam – 1500 
15. Agathiyar kanma kaandom 300 
16. Kumbamuni balavagadam 
17. Yoogi vaidhya sindhamani 
18. Bala vaidhya bodhini nool 
19. Gurunadi sasthiram 
20. Agathiyar 2000 




1. Nelson textbook of pediatrics Volume I & II 18th edition 
2. Rook’s textbook of Dermatology – Tony burns 2004. 
3. Pediatric dermatology Sandipar Dhar – 2008 
4. Essential pediatrics – O.P.Ghai 
5. The wealth of India 
6. Natkarni’s Indian Materia Medica 
7. Principles and pratice of medicine – Davidson. 
8. Social and preventive medicine – Part & Park 
9. Practice of dematology by Dr. P.N Behl. 
10. Text Book of Human Anatomy – BD chaurasia. 
11.  Essentials of Medical Physiology – K.Sembulingam. 
12. Pediatric clinical Adviser- Garfunkel, Kaczorowski and christy. 
13. The short textbook of Pediatrics – Suraj Gupte. 
14. Essentials in Dermatology – DM Thappa. 
15. Dermatology secrets plus- James fitzpatrick, Joseph Morelli. 
16. Textbook of pediatric dermatology – Arun C Inamadar,    
       S.Sacchidanand. 
17. Textbook of Biochemistry – U.Satyanarayana. 
